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Evidence suggests that reticular- and peripheral noxious-stimulation activate an 
ascending system that modulates hippocampal neural responses during behavioral 
arousal.  Indeed, the two stimuli and behavioral arousal elicit hippocampal theta 
activation and the suppression of intra-hippocampal synaptic transmission between 
dorsal hippocampal fields CA3 to CA1.  The suppression of synaptic transmission is 
marked by a decrease in the amplitude of CA1 population spike (PS) evoked on CA3 
stimulation.  Interestingly, such neural responses in CA1 are also elicited by 
microinjection of the cholinergic agonist carbachol into the hypothalamic 
supramammillary nucleus (SuM).  Accordingly, the present study explored the 
hypothesis that cholinergic mechanisms in the SuM underpin the modulation of the 
neural activity in the dorsal hippocampus field CA1 to reticular stimulation and 
peripheral application of a noxious stimulus.   
 
Investigations were carried out in vivo in anaesthetized rat using electrophysiological 
and immunocytochemical techniques.  Pharmacological investigations showed that 
intra-SuM microinjection of carbachol evoked both theta activation and PS 
suppression at short latency that is consistent with a previous report from the 
laboratory.  In addition, it was found that these effects of carbachol were antagonized 
by prior microinjection of the cholinergic receptor antagonists, namely atropine and 
mecamylamine which are antagonists’ at muscarinic and nicotinic receptors, 
respectively.  The effect of the antagonists was selective insofar that they did not 
antagonize the CA1 theta activation and PS suppression evoked by intra-SuM 
glutamate.   
 vii 
 
Subsequent investigations revealed that microinjection of mecamylamine, but not 
atropine, into the lateral SuM selectively attenuated the responses elicited in CA1 by 
stimulation in the region of the reticular pontis oralis (i.e. reticular stimulation) or on 
nociceptive activation with hind paw injection of formalin (5%, 0.05ml); whereas, 
microinjection of mecamylamine into the medial SuM did not affect the hippocampal 
responses elicited by the two stimuli.  Furthermore, application of mecamylamine 
into the lateral SuM attenuated the CA1 responses induced by injection of formalin 
into the contralateral, but not the ipsilateral hind paw.  The lateralization of drug 
effect is consistent with the predominant unilateral anatomical connections between 
the SuM and the septohippocampal region. 
 
Immunocytochemical investigations showed that microinjection of carbachol alone 
into the lateral SuM, but not the medial SuM, elicited the induction of c-Fos protein, 
especially in the ipsilateral dentate gyrus granule cell layer.  On the other hand, c-Fos 
expression was relatively low in the ipsilateral fields CA3 and CA1.  c-Fos protein is 
a transcription protein that is expressed in neurons on synaptic excitation.  Double 
labeling study provided evidence that intra-SuM carbachol induced c-Fos in 
GABAergic inhibitory interneurons of the hippocampus as well. 
 
Taken together, the results provide novel evidence that nicotinic cholinoceptive 
neurons in the lateral SuM are common elements of the neural drive(s) to the 
hippocampus on reticular activation and noxious stimulation.  Furthermore, 
cholinergic stimulation of the lateral SuM provides a strong excitatory drive 
impinging onto the dentate granule cells leading to c-Fos molecular plasticity and also 
 viii 
activates population of GABAergic inhibitory hippocampal interneurons.  The latter 
might be elements of the neural drive that modulate the excitability of principal 
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1.1 The hippocampus 
 
The hippocampus is a layered allocortical structure and forms part of the greater 
hippocampal formation, which includes the dentate gyrus and the subiculum.  In the 
rat, the hippocampus forms a C-shape structure – from the septal nucleus rostrally to 
the temporal lobe caudally.  The long axis and the orthogonal axes of the 
hippocampus were identified as the septotemporal and transverse axis respectively.  
The hippocampus can be regionally divided into distinct cytoarchitectural different 
subfields based on their cellular components.  The three main subfields of the 
hippocampus are the field CA1, field CA3 and dentate gyrus (DG).  The CA2 subfield 
is a small region which is rarely studied (Amaral and Witter, 1989).   
 
1.1.1 Hippocampal cytoarchitecture 
 
Neurons of the hippocampus are generally classified as principal and non principal 
cells (Amaral and Lavenex, 2007).  The granule cells of the DG and the pyramidal 
cell of the CA subfields are the principal cells and are 90% of the total cell population 
(Olbricht and Braak, 1985).  The remaining non-principal cells are the heterogeneous 
inhibitory interneurons that are located throughout the hippocampus.  These 
interneurons play a critical role in sculpting principal cell activity and excitability (see 
section 1.1.3 Interneurons of the hippocampus).  The hippocampus is also divided into 
layers or stratum.  While the principal cells occupy the stratum pyramidale and 
stratum granulosum, the non-principal cells are homogeneously distributed 
throughout the hippocampus (Freund and Buzsaki, 1996).   
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The soma of pyramidal cells are located in the stratum pyramidale and form a 3-4 
soma thick layer.  A single apical dendritic tree extends from the soma and into the 
stratum radiatum, where several processes are emitted.  These dendritic branches 
terminate in the stratum lacunosum moleculare.  Basal dendrites emerge from the 
soma and enter the stratum oriens where a dense arborisation is formed.  Axons exit 
the soma and enter the alveus overlying the stratum oriens before leaving the 
hippocampus.  The morphology of the hippocampal field CA3 pyramidal cells appear 
to be similar to that of CA1.  However, CA3 pyramidal cell axons entering the field 
CA1 project and terminate at the stratum oriens and radiatum of the ipsilateral field 
CA1 (Schaffer collaterals) or to the ipsilateral and contralateral CA3 pyramidal cells 
(associational connections).  Also, the extent of dendritic arborisation differs 
depending on the location of the pyramidal cell.  Pyramidal cells located proximal to 
the dentate gyrus have shorter dendritic tree and do not extend into the stratum 
lacunosum moleculare while dendrites of pyramidal cells distal to the dentate gyrus 
shows extensive distal dendritic arborisation (Ishizuka et al., 1995).   
 
Granule cells of the DG form a V or U shaped structure (depending on the 
septotemporal level) which comprises of the supra- and infra-pyramidal blades of the 
dentate gyrus.  Soma of the granule cells forms a 4-8 soma thick densely packed layer 
of the DG.  The dendritic tree is characteristically cone shaped and terminates at the 
hippocampal fissure after coursing through the molecular layer of the dentate gyrus.  
The axon emerges from the opposite pole of the soma and enters the adjacent hilar 
region, where it courses towards the CA3 field.  Granule cells axons also terminate 
onto the dendrites of mossy cells, the principal cells of the hilar region.  The dendrites 
of mossy cells are usually restricted to the hilar region.  These dendrites are covered 
 4 
in spines which are the postsynaptic to the granule cell axons.  Axons of mossy cells 
terminate on the inner one –third of the granule cells dendrites located in the 
molecular layer of the DG. 
 
1.1.2 Intrahippocampal circuitry 
 
The major intrinsic hippocampal excitatory connections or the trisynaptic pathway 
begins with the entorhinal cortical afferents to the dentate granule cells which in turn 
excite the CA3 pyramidal cells via the mossy fibers.  This leads to the excitation of 
CA1 pyramidal cells by means of the Schaffer’s collateral projection from the CA3 
pyramidal cells (Herreras et al., 1987; Ishizuka et al., 1990).   
 
The entorhinal cortex is one of the main sources of inputs into the hippocampus 
(Witter, 2007).  It is a six-layered cortical region and is divided into the medial and 
lateral entorhinal areas.  Fibers originating from layers II of the entorhinal cortex form 
the perforant pathway and terminate mainly onto the distal dendrites of the granule 
cells of dentate gyrus.  Afferents from the medial entorhinal area terminates in the 
middle one-third while those from the lateral entorhinal area terminate in the outer 
one-third of the molecular layer.  The perforant pathway is organized in a 
topographical fashion.  The septal dentate gyrus receives inputs from the lateral and 
caudal entorhinal areas while the temporal dentate gyrus receives inputs from the 
medial and rostral entorhinal areas.  In addition, the entorhinal cortex projects to the 
CA1 pyramidal cells with axons terminating the stratum lacunosum-moleculare.   
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The projection course taken by the mossy fibers of the granule cells was shown using 
the anterograde tracer Phaseolus vulgaris leucoagglutinin (PHAL) microinjected into 
the granule layer of the DG (Amaral and Witter, 1989).  These fibers leave the dentate 
gyrus and enter the CA3 field via stratum lucidum.  The mossy fibers then terminate 
on the spines of the proximal apical dendrites of the stratum radiatum of the ipsilateral 
CA3 pyramidal cells.  This projection is restricted and extends in a lamellar fashion 
along the same septotemporal level (Amaral and Witter, 1989).   
 
The Schaffer’s collateral axonal projection from the CA3 to the CA1 fields of the 
hippocampus has been described also using PHAL tracer and intracellular labeling 
methods (Amaral and Witter, 1989; Li et al., 1994).  The Schaffer’s collaterals 
terminate in the stratum radiatum and oriens of the CA1 pyramidal cells.  Anterograde 
labeling with PHAL revealed a subiculo-dentate gradient in termination of the 
Schaffer’s collateral (Amaral and Witter, 1989).  CA3 pyramidal cells that are located 
close to the dentate gyrus, i.e. CA3c, projects to the septal CA1 and nearer to the 
subicular border and their axons mostly terminate in the superficial stratum radiatum.  
CA3 pyramidal cells closer to the CA1 region, i.e. CA3a, project to the temporal 
CA1, with terminals in the deeper stratum radiatum and oriens.   
 
CA1 pyramidal cells axons course through the stratum oriens and alveus towards the 
subiculum.  Local collaterals that arise from the CA1 axons distribute in the stratum 





1.1.3 Interneurons of the hippocampus 
 
Inhibitory interneurons form part of the intrinsic hippocampal network.  These 
neurons of the hippocampus can be broadly classified as axo-axonic (and somatic) or 
axo-dendritic interneurons (Freund and Buzsaki, 1996).  The former group comprises 
of chandelier and basket cells while oriens-lacunosum moleculare (O-LM), 
bistratified and trilaminar neurons are from the latter group.  The main axons of axo-
axonic interneurons are myelinated and run tangentially to its soma, while emitting 
collaterals that arborize and form dense multiple synapses in the prisomatic region of 
the principal cells.  Axons of axo-dendritic neurons however are unmyelinated and 
arborize upon reaching the target laminae.   
 
A classical axo-axonic/somatic interneuron is the basket cell.  Based upon biocytin 
visualization, the axons of basket cells arborise only within the stratum pyramidale 
and do not penetrate the other layers of the hippocampus.  The axons form 
symmetrical synapses with the soma and initial axon segments of the neighboring 
pyramidal cell as well as other parvalbumin (PV) expressing positive basket cells (Sik 
et al., 1995).  PV is a calcium buffering protein and is used as a marker for a subset of 
hippocampal interneuron.  The dendritic tree of basket cells, however, arborises in the 
stratum oriens, pyramidale and lacunosum-moleculare and receives inputs from 
neighboring pyramidal cells (Freund and Buzsaki, 1996).  Furthermore, PHAL 
labeling of entorhinal neurons labeled axon terminals that form synapses with PV-
labeled dendrites of basket cells, indicating that neurons of the entorhinal cortex are 
able to modulate pyramidal cell activity via a feed forward inhibitory mechanism with 
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a short latency (Kiss et al., 1996; Pawelzik et al., 2002; see section 1.1.4 Pyramidal 
cell physiology).   
 
Among the axo-dendritic interneruons, the O-LM interneuron has also been well 
studied.  The dendritic tree of O-LM interneurons is confined to the stratum oriens 
and alveus, while the axon penetrates the hippocampus and arborise at the stratum 
lacunosum moleculare (Sik et al., 1995).  These interneurons are immunoreactive for 
somatostatin (SOM; Freund and Buzsaki, 1996).  SOM positive axons were shown to 
perfectly overlap with the terminals of entorhinal afferents in the stratum lacunosum 
moleculare, suggesting that the SOM positive interneurons could exert an inhibitory 
regulation of entorhinal synapses terminating on the distal dendrites of the pyramidal 
cells (Blasco-Ibanez and Freund, 1995; Katona et al., 1999).   
 
Besides the above two types, a number of other interneurons are also localized in the 
hippocampus and dentate gyrus (Freund and Buzsaki, 1996).  An example is the 
population of interneurons that is positive for neuronal nitric oxide synthase (nNOS).  
The nNOS is an enzyme involved in the synthesis of the water and lipid soluble nitric 
oxide, which acts as a neuronal messenger.  nNOS positive interneurons are unevenly 
distributed, with soma visualized in all layers of the hippocampal subfields.  In spite 
of the distributed location, the axons of nNOS positive interneurons form dense 
arborisation in the stratum lacunosum moleculare (Freund and Buzsaki, 1996).  In 
addition, long range projecting nNOS immunoreactive interneurons, also known as 
ivy cells have been identified.  The axons of ivy cells originate from the stratum 
pyramidale of field CA1 and pentrates the field CA3 and hilar region of the ipsilateral 
hippocampus (Sik et al., 1994).  Such long projecting interneurons were activated by 
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recurrent excitation of pyramidal cells in a similar fashion to O-LM cells (see section 
1.1.4 Pyramidal cell physiology).  The function of such long projecting neurons is 
hypothesized to synchronise the generation of action potentials of spatially distant 
populations of neurons (Sik et al., 1994).  Interestingly, using immunocytochemistry 
and mRNA in situ hybridization methods, the nitric oxide-sensitive guanyl cyclase 
(NOsGC), acting as receptors for NO, were detected in pyramidal cells and SOM, 
nNOS and PV immunoreactive interneurons.  This suggests that NO as a signaling 
molecule could modulate pyramidal cell activity post- and pre-synaptically (Szabadits 
et al., 2007).   
 
Although the role of cortical interneurons appears to be either excitatory or inhibitory 
in nature, the interneurons of the hippocampus have been shown to be exclusively 
inhibitory in nature (Glickfield et al., 2009).  It is notable that inhibition of pyramidal 
cell excitability employs different mechanisms and is dependent on site of inhibition.  
Somatic inhibition modulates pyramidal cell efferent signaling by limiting sodium 
channel dependent spike discharges while dendritic inhibition controls afferent inputs 
by suppressing dendritic calcium spikes and restricting spread of depolarization 
(Miles et al., 1996).   
 
1.1.4 Pyramidal cell physiology 
 
Both spontaneous and evoked responses of hippocampal pyramidal cells have been 
explored.  In context of the former, in vivo intracellular single cell recordings indicate 
that hippocampal pyramidal cells discharge spontaneously with single spike or burst 
of spikes (Kandel and Spencer, 1961).  Burst firing is observed as a ‘complex spike’ 
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discharge that comprises of 2-10 action potentials with decreasing amplitude and 
short interspike time intervals of 3 to 10ms.  The generation of a burst of action 
potentials is suggested to be mediated by a persistent sodium current at the apical 
dendrite, resulting in a depolarizing post spike potential (Azouz et al., 1996; Yue et 
al., 2005).  Indeed, manipulation of this potential by hyperpolarizing or depolarizing 
the cell beyond a threshold level attenuated the persistent sodium current and the 
subsequent after depolarizing potential.  This prevented the depolarizing induced 
pyramidal cell bursting (Jensen et al., 1996; Yue et al., 2005).   
 
Afferent stimulation also excites pyramidal cells and, indeed, can elicit synchronized 
excitation of population of pyramidal cells.  For example, high intensity Schaffer’s 
collaterals afferent stimulation evoked a large negative going potential in the apical 
dendrites, which is reflective of intracellular excitatory post synaptic potential 
(EPSP).  This negative potential reverses in the pyramidal cell layer.  Increasing the 
Schaffer’s collateral stimulation intensity generates a negative population spike that is 
superimposed on a positive field of EPSP.  Following the population spike, a large 
positive waveform is recorded.  The amplitude of the population spike is a reflection 
of the number of pyramidal cells discharging synchronously while the positive 
waveform reflects the intracellular inhibitory post synaptic potential in the pyramidal 
cells (IPSP; Andersen et al., 1971).   
 
The generation of population spikes was shown to be at the proximal dendritic 
compartment in vivo (Herreras, 1990; Kloosterman et al, 2001).  Based on current 
source density (CSD) study, the current sink generated with the shortest latency was 
in the proximal apical dendrites when stimulation was delivered to the Schaffer’s 
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collaterals (Kloosterman et al., 2001).  This population spike then travels towards the 
soma and also back-propagates towards the apical dendrites.  Stimulation of the 
afferents in the region of basal dendrites however generated a population spike that 
was initiated at the axon initial segment near the cell body.  On the other hand, latency 
studies in hippocampal slices indicate that the population spike is generated at the cell 
body region upon orthodromic stimulation of the stratum radiatum (Turner et al., 
1991).  The generation site however shifts to the proximal apical dendrites at higher 
intensity stimulation, where tetrodotoxin (TTX)-sensitive sodium channels of the 
apical dendrites are recruited.   
 
The response of pyramidal cells is modulated by the local interneurons via feed 
forward and feedback inhibition.  In recurrent or feedback inactivation, recruited 
pyramidal cells activate inhibitory interneurons which in turn impinge on the neurons 
that activate them.  In feed forward inhibition, the interneurons receive inputs directly 
from afferents and its activation inhibits the concomitantly activated pyramidal cells.  
Indeed, afferent stimulation-evoked excitation of a basket cell always preceded the 
extracellular population spike of the concurrently recorded pyramidal cell (Buzsaki 
and Eidelberg, 1982; Sik et al., 1995; Ylinen et al., 1995).  Moreover, stimulation of 
the pyramidal cell apical afferents that was subthreshold to excitation of pyramidal 
cell generated intracellular IPSPs in the neurons.  The feed-forward IPSP attenuated 
the size of depolarization attained by the pyramidal EPSPs evoked at higher intensity 
afferent stimulation (Turner, 1990).   
 
The interneurons may also discharge at the positive field potential after the population 
spike, i.e. after pyramidal cell activation and mediate feedback inhibition (Buzsaki 
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and Eidelberg, 1982; Lacaille et al., 1987).  In line with this, interneurons such as the 
O-LM interneuron which impinge on pyramidal cells are excited by stimulation of the 
pyramidal cells (Gulyas et al. 1993).  Indeed, interaction of the pyramidal cells and O-
LM interneurons are reciprocal since i) ischemic degeneration of pyramidal cells 
resulted in loss of presynaptic elements terminating on SOM positive dendrites of O-
LM interneurons (Blasco-Ibanez and Freund, 1995); ii) commissural stimulation 
evoked an action potential of the O-LM interneuron after the generation of an 
extracellular pyramidal cell population spike (Sik et al., 1995); and iii) stimulation of 
the stratum radiatum generated action potentials in the pyramidal cell which were 
blocked by exciting the O-LM interneuron (Lacaille et al., 1987).  In this regard, in a 
paired pulse paradigm, where Schaffer’s collaterals are stimulated twice at 
appropriate (milliseconds) inter-pulse interval, the amplitude of the 2
nd
 population 
spike is smaller than the first spike.  This paired-pulse suppression is attenuated by 
intra-hippocampal application of the GABAA receptor antagonist, bicuculline (Freund 
et al., 1990; Zheng and Khanna, 2008).   
 
1.1.5 Septo-hippocampal connections  
 
The septohippocampal region is reciprocally connected.  Anatomical techniques, 
especially retro- and anterograde tracer techniques, indicate that the septal projection 
to the hippocampus is predominantly from the medial septum (MS) and the vertical 
limb of the diagonal band of Broca (VLDBB).  The septal afferents connect to the 
hippocampus via the fimbria, the dorsal fornix and the supracallosal striae (Swanson 
and Cowan, 1979; Monmaur and Thomson, 1983; Woolf et al., 1984; Nyakas et al., 
1987; Dutar et al., 1995).  The projections follow a mediolateral topographical 
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arrangement, whereby neurons located along the midline MS projects to the 
dorsal/septal aspects of the hippocampus while more lateral neurons project to the 
ventral/temporal aspects (Meibach et al., 1977; Nyakas et al., 1987; Gaykema et al., 
1990).  In addition, the septohippocampal projections are dominantly ipsilateral in 
nature (Monmaur and Thomson, 1983, Woolf et al., 1984).   
 
The septohippocampal projection is diverse.  For example, PHAL labeled 
septohippocampal axons are either relatively thick (type 1) that terminate in a basket-
like fashion around their target neurons or thin (type 2) with en passant varicosities 
(Nyakas et al., 1987; Freund and Antal, 1988; Gaykema et al., 1990).  Interestingly, 
the type 1 fibers infiltrate the stratum oriens, statum radiatum and stratum lacunosum-
moleculare and form basketlike formation around the target neurons.  These afferents 
are characteristics of the parvalbumin positive septohippocampal neurons that are 
GABA positive (Nyakas et al., 1987; Freund and Antal, 1988; Freund, 1989) and 
target the cell bodies or dendrites of the hippocampal interneurons (Freund and Antal, 
1988).  Type 2 fibers terminate in all layers of the hippocampus but dominantly in 
stratum oriens and lacunosum-moleculare and may comprise the septohippocampal 
cholinergic afferents (Frotscher and Leranth, 1985; Nyakas et al., 1987).   
 
Likewise, the neuronal population in the MS is diverse.  Based on 
immunohistochemical and RT-PCR methods, the neurons in the medial septum have 
been identified as cholinergic (choline acetyltransferase or ChAT positive), 
GABAergic (glutamic acid decarboxylase or GAD positive) and glutamatergic 
(vesicular glutamate transferase 1 and 2 or VGLUT1 and 2 respectively, expressing) 
neurons (Freund and Antal, 1988; Kiss et al., 1992; Sotty et al., 1993; Manseau et al., 
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2005).  The cholinergic and GABAergic neurons are distributed in a lamellar fashion 
with the GABAergic neurons located in midline of the MS and surrounded by the 
cholinergic neurons.  Glutamatergic neurons are distributed among the cholinergic 
and GABAergic neurons.   
 
Earlier studies, such as the autoradiographic study by Swanson and Cowan (1979), 
indicated that the hippocampal-septal afferents originate from the CA regions and 
terminate dominantly in the ipsilateral lateral septum (LS).  Furthermore, projections 
are arranged in a topographical fashion with neurons along the dorsoseptal to the 
ventrotemporal hippocampus poles terminating along the dorsoventral aspect of the 
lateral septum.  Subsequently, the findings were extended using anterograde and 
retrograde tracers injected into the LS.  Thus, retrograde tracer fluorogold injections 
into the rostral LS labeled neurons of the ipsilateral CA1 pyramidal cells while 
ipsilateral CA3 pyramidal cells were labeled with caudal LS injection of fluorogold 
(Risold and Swanson, 1996).  Biochemically, SOM and calbindin expressing 
interneurons project from the hippocampus to the MS (Toth and Freund, 1992).  
Furthermore, antero- and retrograde experiments using PHAL and fluorogold 
respectively injected into the MS showed that the SOM expressing hippocampal-
septal projection cells are innervated by the PV positive GABAergic MS neurons 
(Takacs et al., 2008), suggesting a hippocampal-forebrain circuitry.   
 
Interestingly, anatomical studies indicate a ‘loop-like connection’ between the 
septohippocampal region and the hypothalamus (Leranth and Kiss, 1996; Risold and 
Swanson, 1996; Borhegyi and Freund, 1998; Borhegyi et al., 1998; Leranth et al., 
1999).  In this context, PHAL and wheat germ agglutinin coupled with horse radish 
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peroxidase (WGA-HRP) tracers experiments coupled with immunocytochemical 
explorations indicate that neurons in the LS, specifically the calretenin or calbindin 
expressing GABAergic neurons at the medial and lateral septum border, projects to 
the lateral supramammillary nucleus (lSuM).  The septohypothalamic calretinin 
positive GABAergic neurons also receive afferent input from the lateral entorhinal 
cortex.  In return, calretinin positive glutamatergic axon terminals from the SuM 
neurons project onto cholinergic neurons in the medial septum, and GABAergic 
neurons in both the medial and lateral septum (see section 1.3.1 Neuronanatomy of 
the supramammilary nucleus: cellular demarcation, afferents and efferents).   
 
1.2 Septohippocampal network activity 
 
Given the reciprocal and loop-like nature of connections, it is not surprising that the 
septum, the hippocampus and the hypothalamus each influence the activity in the 
other two regions.  The interaction between the septum and the hippocampus is 
covered in this section while the modulation by the hypothalamus is described in a 
latter section (see section 1.3 The supramammillary nucleus). 
 
1.2.1 Generation of theta wave activity 
 
The septum and the hippocampus interact to generate the theta rhythm (theta 
electroencephalogram [EEG] or rhythmic slow activity, RSA) which is best recorded 
from the hippocampus.  The theta EEG is regular sinusoidal extracellular waveform 
that reflects rhythmic fluctuation of the intracellular membrane potential at a 
frequency of 3-6Hz in anaesthetized animal and 4-12Hz in behaving animal (Bland, 
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1986; Buzsaki, 2002).  In the anaesthetized animal, theta wave activity may occur 
spontaneously, induced by intracerebral stimulation or with peripheral application of a 
noxious stimulus (Vertes, 1981; Khanna, 1997).  Theta generation in the behaving rat 
is usually observed during voluntary movements and rapid eye moment (REM) sleep 
(Vanderwolf, 1969; Bland, 1986).  In a recent work, the locomotion-induced 
hippocampal theta was described as ‘travelling wave’ along the mediolateral axis 
(Lubenov and Siapas, 2009).  That is, the relative phase of theta recorded from the 
stratum oriens advanced from the medial to the lateral aspect of the lamina while 
remaining constant along the rostrocaudal axis.   
 
A variety of evidences are consistent with the idea that the MS/VLDBB is critical for 
the generation of the hippocampal theta rhythm (Rawlins et al., 1979; Bland 1986; 
Stewart and Fox, 1990; Vertes and Kocsis, 1997; Buzsaki, 2002).  These include, i) 
hippocampal theta induction by electrical stimulation of the reticular formation (Bland 
et al., 1994) or by tail pinch (Bland and Oddie, 1998) results in theta-rhythmic 
discharge of MS cells.  The MS neurons may discharge phase-locked to the negative 
or the positive peak of the hippocampal theta (Brazhnik and Fox, 1997); ii) 
inactivation of the MS by the local anesthetic procaine or by atropine, a muscarinic 
receptor antagonist, attenuates reticularly-induced hippocampal theta (Kirk and 
McNaughton, 1993; Jiang and Khanna, 2004, Li et al., 2007); iii) intra-MS 
microinjection of ZD7288, which blocks hyperpolarization-induced cation channel 
(HCN) current (or Ih) in MS GABAergic neurons, attenuated both exploratory and 
sensory stimulus-evoked hippocampal theta in the freely moving animal (Xu et al., 
2004).  Indeed, the extracellular discharge of putative PV positive GABAergic 
septohippocampal neurons that express HCN preceded the transition of hippocampal 
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EEG from irregular activity to theta rhythm in anaesthetized rat (Hangya et al., 2009); 
iv) lesions of either the cholinergic or the PV positive GABAergic neurons of the MS 
with the neurotoxin 192 IgG-saporin or the glutamate receptor agonist kainic acid, 
attenuated sensory- and exploration-induced power of theta in anaesthetized and 
behaving animal, respectively (Lee et al., 1994; Zheng and Khanna, 2001; Yoder and 
Pang, 2005).  As with the PV positive GABAergic neurons, the cholinergic neurons of 
the MS also project to the hippocampus and exert multiple neural effects in the region 
(Leranth and Frotscher, 1989; Yoder and Pang, 2005; Bassant et al., 1998); v) intra-
MS infusion of NMDA, an agonist at the glutamate NMDA receptor, induced 
sustained hippocampal theta activation and increased the discharge of CA1 theta-
related neurons (Bland et al., 2007).  Conversely, intra-MS infusion of AP5, the 
NMDA receptor antagonist, attenuated tail pinch- and locomotion-induced theta 
power with no affect on theta frequency (Leung and Shen, 2004; Bland et al., 2007).  
Unlike the effect of manipulation of the NMDA receptor in the MS, the intra-MS 
infusion of DNQX, an AMPA receptor antagonist, had no effect on locomotion- 
induced theta (Leung and Shen, 2004).   
 
1.2.2 Depth profile of theta rhythm 
 
The depth profile of the theta field potential in the CA1 region of the hippocampus 
and the corresponding current profiles have been examined in both behaving and 
anaesthetized animals (Green and Rawlins, 1979; Leung, 1984, Buzsaki et al., 1986). 
In the behaving rat, the amplitude of theta increases gradually as the recording 
electrode is moved from the alveus towards the hippocampal fissure.  Two maxima 
are observed, one at the stratum oriens and pyramidale border, and the other at the 
 17 
hippocampal fissure (Buzsaki, 2002).  In addition, the phase of theta is shifted as a 
function of depth from the stratum pyramidale.  A complete reversal, with respect to 
theta recorded at the stratum oriens/pyramidale is seen at the fissure.  Theta depth 
profile however is somewhat different in an anaesthetized animal.  Thus, under 
urethane anesthesia, a null zone is observed at the proximal stratum radiatum together 
with an abrupt phase reversal (Buzsaki et al., 1986).   
 
The differences in theta depth profile between behaving and anaesthetized animal is 
attributed to the variation in dipoles that underpin theta wave activity (Leung et al., 
1984).  A dipole is generated by the perisomatic inhibition at the pyramidal cell layer 
while another is due to excitation at the distal dendritic layer of the CA1 pyramidal 
cells.  It has been proposed that the somatic inhibition is mediated via 
septohippocampal inputs, perhaps by exciting local interneurons that generate a 
current source while entorhinal cortex afferents generates EPSPs in the distal 
dendrites, creating a current sink (Leung et al., 1984; Buzsaki et al., 1986; Brankack 
et al., 1993).  This rhythmic generation of current source and sink leads to fluctuations 
of the membrane potential which is recorded extracellularly as theta rhythm (Buzsaki 
et al., 1986; Smythe et al., 1992, Toth et al., 1997; Brazhnik and Fox, 1999; Buzsaki, 
2002; Yoder and Pang, 2005).  The profile, i.e. the gradual phase shift of the theta 
wave with depth is affected by vector summation of the two dipoles.  In this scenario, 
the absence or attenuation of the distal dendritic excitatory inputs while under 
urethane anesthesia results in the abrupt phase reversal of theta.  Interestingly, recent 
work suggests that each anatomically distinct principal cell layer of the hippocampus, 
i.e. CA1, CA3 and DG, generates independent theta dipoles (Montgomery et al., 
2009).  Phase analysis of local theta EEG and measurement of CSD recorded via an 
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array of silicon probes with 96 recording sites showed that within each layer, theta 
and CSD exhibited the highest coherence while inter-layer comparisons showed the 
lowest coherence.   
 
Several evidences are in agreement with the two dipole hypothesis.  For example, 
identified putative inhibitory GABA interneurons located around the stratum 
pyramidale exhibited an increase in firing during theta (Klausberger et al., 2003).  
Moreover, the interneurons preferentially discharged at the hyperpolarizing phase of 
somatic membrane potential of pyramidal cells (Buzsaki et al., 1983; Ylinen et al., 
1995; Klausberger et al., 2003).  On the other hand, dendritic depolarization is 
observed in correspondence with somatic hyperpolarization during theta (Kamondi et 
al., 1998).   
 
1.2.3 Theta associated temporal encoding and ‘signal-to-noise’ processing in 
CA1 
 
Hippocampal theta is linked with processing of information associated with 
biologically relevant events and may provide substrate for encoding of animals’ 
location during exploration of an environment.  Indeed, in behaving animals, the 
complex-spike, putative pyramidal cell in CA1 discharge especially in correlation 
with the animal’s spatial position in a given environment (O’Keefe and Dostrovsky, 
1971; O’Keefe, 1976).  Such neurons are known as place cells and the location where 
a place cell fires maximally (i.e. rate encoding) is its place field.  Strikingly, the 
temporal pattern of complex-spike firing is altered as the animal enters the cell’s place 
field (O’Keefe and Recce, 1993).  That is, the phase relationship between the 
 19 
discharge of a complex-spike cell and the EEG theta activity changes systematically 
as the animal traversed the place field of the cell with the cell firing successively at 
earlier stage of the concomitant theta cycle while moving through the place field 
(phase precession or temporal encoding).  The phase precession is also noted in 
parallel with increasing cell discharge rate and there is some suggestion that the use of 
such temporal encoding together with rate coding significantly enhances the accuracy 
of reconstructing the animal’s position from neuronal discharge (Jensen and Lisman, 
2000).  Interestingly, because of the parallel increase in cell activity and phase 
precession it has been proposed that, at least in part, phase precession is a function of 
the strength of excitation impinging on the cell and the interplay with inhibition 
during the theta cycle (Harris et al., 2002; Mehta et al, 2002).  As such, the hypothesis 
is consistent with in vitro evidence from hippocampal slices (Magee, 2001; Gasparini 
and Magee, 2006).  In this regard, Magee (2001) noted that the passage of theta 
rhythmic hyperpolarizing current through a somatic intracellular electrode to mimic 
the condition during actual theta activation evoked a ‘rebound’ action potential at the 
peak of the depolarization shift that followed the hyperpolarization.  On the other 
hand, when the rhythmic hyperpolarization was accompanied by out of phase (i.e. at 
180
0
) theta rhythmic dendritic depolarization to mimic rhythmic afferent excitatory 
input seen during theta, the action potential discharge increased in frequency and 
advanced temporally compared to the ‘rebound’ action potential.  The temporal 
advance was a function of the strength of dendritic depolarization (also see Gasparini 
and Magee, 2006).  In the experiments, the rhythmic dendritic depolarization was 
induced by either passage of current through another intracellular electrode or by 
theta-patterned stimulation of afferent input to CA1 pyramidal cells.    
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Interestingly, there are some similarities between CA1 responses in behaving animals 
and those observed in anaesthetized animal on intense peripheral noxious stimulation 
with hind paw injection of formalin (Khanna, 1997).  Thus, as with place cell firing 
during animal exploration, the formalin-induced excitation of CA1 complex-spike 
cells is observed in parallel with local theta activation (Khanna, 1997) and is theta-
rhythmic (Tai et al., 2006).  Importantly, the CA1 response to hind paw injection of 
formalin is akin to ‘signal-to-noise’ marked by excitation of select (~30%) population 
of neurons (i.e. ‘signal) with high spontaneous activity against the background of 
widespread suppression of complex spike cells with low spontaneous activity (i.e. 
suppression of ‘noise’; Khanna, 1997).  Similarly, only 30-55% of pyramidal cells are 
excited in a given environment, the proportion being higher when the environment is 
novel (Thompson and Best, 1989; Wilson and McNaughton, 1993; Gothard et al., 
1996; Guzowski et al., 1999; Vazdarjanova and Guzowski, 2004; Karlsson and Frank, 
2009; Miyashita et al., 2009).  Intriguingly, place cells also had higher background 
activity in the environment with their place fields while cells that had no place field in 
the environment were virtually silent (silent cells; Thompson and Best, 1989).  
However, the discharge rate of place cells and silent cells was indistinguishable 
during slow wave sleep.  Linking the two patterns suggests that active inhibition 
underpins the generation of silent cells in behaving animal, as with suppression of 
‘noise’ in anaesthetized animal (Khanna, 1997; Zheng and Khanna, 2001; 2008; 
Ikonen et al., 2002).   
 
The mechanism of selective excitation and inhibition of hippocampal pyramidal cells 
during formalin and spatial encoding has been shown to be modulated by the 
cholinergic neurotransmitter system.  For example, acute microdialysis of 
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scopolamine, a non specific cholinergic receptor antagonist into the CA1 region of the 
hippocampus reduced the firing rate of the place cells while the animal was in its 
correspondent place fields (Brazhnik et al., 2004).  Conversely, when the animal was 
outside the place fields, the firing rate of the place cells increased.  In addition, the 
size of the place fields decreased upon subsequent exposure to the same environment.  
Interestingly, the effect of scopolamine was replicated when a mixture of 
methoctramine, an m2 and m4 cholinergic receptor subtype antagonist, and 
pirenzepine, an m1 cholinergic receptor antagonist, were applied to the hippocampus.  
This suggests that the postsynaptic m1 receptors and the presynaptic m2 and m4 
receptors are in a position to modulate hippocampal excitability and recruitment 
during spatial mapping.   
 
Chronic destruction of the septal cholinergic neurons also affected both the place cell 
discharge and formalin-induced ‘signal-to-noise’ processing (Zheng and Khanna, 
2001; Ikonen et al., 2002).  In this context, the loss of cholinergic septal neurons 
resulted in place cells rigidity whereby about 22% of place cells showed a similar 
place field in the novel environment compared to the familiar environment.  In 
comparison, place fields of non-lesion animals underwent remapping with subsequent 
exposure to the novel environment.  While, in anaesthetized animal such lesion 
resulted in increase in the background discharge of pyramidal cells and a loss of 
inhibition of CA1 pyramidal cell discharges evoked by hind paw injection of formalin 
(Zheng and Khanna, 2001).  As in behaving animal, the formalin-induced pyramidal 
cell excitation as such was not affected.  In addition, the cholinergic lesion precluded 
the formalin-induced excitation of putative GABAergic interneurons of the field CA1 
in anaesthetized rat (Zheng and Khanna, 2001).  These effects of cholinergic lesion on 
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CA1 pyramidal cell discharge were replicated with intra-hippocampal microinjection 
of bicuculline, the GABAA receptor antagonist (Zheng and Khanna, 2008).  
Collectively, the evidence is consistent with the idea that formalin injection excites 
medial septal cholinergic neurons which in turn activate hippocampal GABAergic 
interneurons that mediate the formalin pain-induced CA1 pyramidal cell suppression.  
In addition, the findings point to a non-overlapping excitatory drive to CA1 following 
hind paw injection of formalin.   
 
1.3 The supramammillary nucleus 
 
1.3.1 Neuroanatomy of the supramammillary nucleus: cellular demarcation, 
efferents and afferents 
 
The supramammillary nucleus (SuM) is an anatomically and neurochemically distinct 
structure of the posterior hypothalamus (PH), which is part of the diencephalon.  
Ventrally, the SuM is bordered by the mammillary body and the 
pedunculomammillary tract.  The lateral hypothalamus and the PH lie laterally and 
dorsally to the SuM respectively.   
 
In a recent review, the SuM was demarcated and further sub-classified based on the 
morphology and neurochemistry of the neuronal populations (Pan and McNaughton, 
2004).  Thus, the SuM, as a whole, contains calretinin-like immunoreactive (LI) and 
cholecystokinin-LI cells.  The central region of the SuM consists of a population of 
smaller neurons and is labeled as the parvicellular SuM (SuMp).  This region is 
relatively rich in dopamine-LI and substance P-LI cell bodies.  The region lateral to 
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this is labeled as the grandicellular SuM (SuMg) given that it comprises of larger 
sized neurons.  SuMg is located around the mamillothalamic tract and has relatively 
low level of substance P-LI.  The most lateral aspect of the SuM is labeled as the 
supramammillary shell (SuMs) and comprises of smaller but less packed neurons.  
The SuMp and part of the SuMg overlaps with boundaries of the medial SuM (or 
SuMM of Paxinos and Watson, 1997; also Jiang and Khanna, 2004, 2006), while part 
of SuMg and the SuMs overlaps with the boundaries of the lateral SuM (or SuML of 
Paxinos and Watson, 1997; also Jiang and Khanna, 2004, 2006).   
 
The pattern of the efferent projections from the neurons in SuM has been explored 
using anterograde and retrograde tracers and transmitter immunocytochemistry that 
reveals that these neurons project primarily via the medial forebrain bundle to 
forebrain structures such as: (a) the MS innervating both PV positive (GABAergic) 
and the ChAT positive (cholinergic) neurons therein; (b) LS, especially the dorsal and 
intermediate LS nuclei; (c) the hippocampus, especially the DG; and (d) other 
structures such as the mammillary nuclei (especially lateral mammillary nucleus), 
thalamus, posterior hypothalamus, amygdala, medial prefrontal and the entorhinal 
cortices (Ottersen, 1980; Swanson, 1982; Haglund et al., 1984; Saper, 1985; Gonzalo-
Ruiz et al., 1992; Vertes, 1992; Hayakawa and Zyo, 1994; Leranth and Kiss, 1996; 
Borhegyi et al., 1998; Kiss et al., 2000; Vertes and McKenna, 2000).  The SuM 
efferents to MS, LS and DG chiefly arise from the lateral SuM, are dominantly 
ipsilateral and may utilize glutamate as a transmitter.  Within the DG, dense PHAL 
labeled axon terminals are observed to terminate in the outer granular layer and inner 
molecular layer targeting mostly the principal neurons (Magloczky et al., 1994).  The 
dopaminergic cells of the medial SuM also project to the LS, and as well to 
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mammillary nuclei, especially the lateral mammillary nucleus (Gonzalo-Ruiz et al., 
1992; Hayakawa and Zyo, 1994). 
 
Retrograde and anterograde tracers have also identified both ascending and 
descending afferents from the brainstem and forebrain, respectively, to the SuM.  For 
example, WGA-HRP microinjected into the rostral-caudal extent of the lateral SuM 
retrogradely labeled neurons in the MS, the lateral dorsal tegmental nucleus (LDTg) 
and the dorsal and median raphe (DR and MR, respectively; Gonzalo-Ruiz et al., 
1999).  Indeed, injection of the anterograde tracer PHAL into the DR and MR densely 
labeled the entire extent of the SuM (Vertes et al., 1999; Vertes, 1991).  In parallel, 
dense labeling of the ventral tegmental area (VTA) and the medial mammillary body 
were also detected with DR injection (Vertes, 1991).  Only rostral but not caudal DR 
sites labeled the posterior hypothalamus (Vertes, 1991).   
 
PHAL injection into both the infra- and prelimbic area labeled the SuM, although the 
medial SuM was more intensely stained compared to the lateral SuM (Hurley et al., 
1991; Vertes, 2004).  Also, caudal injections into the infra- and prelimbic areas 
resulted in a heavier staining of the SuM in comparison to more rostral injections.  
The posterior and lateral hypothalamic nuclei were also labeled but only with 
infralimbic and not prelimbic microinjections of the anterograde dye.  Unlike the MR 
and DR, the mammillary body was void of any labeled fibers from the infra- and 
prelimbic areas (Vertes, 2004).   
 
The projection from the rostral pontine oralis (RPO) to the SuM remains unclear.  
Earlier work using [3H]leucine as an anterograde tracer showed that the SuM receives 
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ascending afferents from the RPO nucleus of the brainstem (Vertes and Martin, 1988).  
However, microinjection of WGA-HRP into the SuM did not reveal any afferents 
originating from the RPO nucleus (Hayakawa et al., 1993).  Rather, the authors 
proposed that the label in SuM with [3H]leucine microinjection into RPO reflected 
the absorption of the tracer by fibers of passage through the RPO (Hayakawa et al., 
1993).   
 
Double labeling studies, employing retrograde transport of WGA-HRP microinjected 
into SuM combined with transmitter immunocytochemistry, have identified the 
neurochemical nature of number of afferents to the SuM (Gonazalo-Ruiz et al., 1991).  
For example, the majority (90%) of the projection neurons from the LDTg to the SuM 
were positively labeled for ChAT.  80-85% of labeled MS neurons were also positive 
for ChAT while the remaining neurons were labeled for GABA, glutamate, substance 
P or neurotensin.  Interestingly, a double labeling study showed that the GABAergic 
projection from the MS complex to SuM originated from calretinin (CR) positive 
neurons (Borhegyi and Freund, 1998).  The CR neurons are mostly located at the 
border of the MS and the LS and are separate from PV positive GABAergic neurons 
that are located mostly around the midline of the MS.  The PV positive neurons give 
rise to a weak projection to the SuM (Borhegyi and Freund, 1998).  The MS axons 
emerging from the CR positive neurons terminated both in the medial SuM, and the 
lateral SuM area surrounding the mamillary peduncle.   
 
The SuM also receives glutamatergic afferents from various structures such as the 
MS, LS, VLDBB and LDTg (Gonzalo-Ruiz et al., 1999; Kiss et al., 2002).  Based on 
retrograde labeling with [3H]D-aspartate, the glutamatergic neurons appear to 
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terminate along the anterior-posterior extent of the lateral SuM (Kiss et al., 2002).  A 
proportion of the glutamatergic neurons located at the MS and LS border, that projects 
to the SuM, were also double labeled for calbindin (CB) or CR (Borhegyi and Freund, 
1988; Kiss et al., 2002).   
 
1.3.2 Neurophysiology of the supramammillary nucleus 
 
The SuM is implicated in modulation of the hippocampal synaptic activity and theta 
activation in the region.  In context of the former, chemical or electrical stimulation of 
the lateral SuM potentiated the perforant path stimulation-induced population spike in 
the dentate gyrus (Mizumori et al., 1989; Carre and Harley, 1991).  A similar 
facilitation was also observed with stimulation of the MS.  However, the MS, but not 
SuM stimulation-induced facilitation was eliminated by transaction of the dorsal 
fornix/fimbria.  This suggests that the SuM modulation of synaptic excitability in the 
DG is independent of MS activity (Mizumori et al., 1989) and, perhaps, involved the 
direct projection from the SuM to DG (see section 1.3.1 Neuroanatomy of the 
supramammillary nucleus).  The potentiation of DG population spike upon SuM 
stimulation was observed in absence of change in field EPSP.  On the other hand, the 
discharge probability of inhibitory basket cells was reduced with SuM stimulation, 
thus raising the possibility that SuM-induced facilitation of granule cell excitability is 
mediated by disinhibition (Mizumori et al., 1989).  In addition, stimulation of the 
SuM induced long term potentiation (LTP) of the dentate population spike evoked 
upon weak tetanic stimulus of the perforant path (Nakanishi et al., 2001).   
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In contrast, chemical manipulation of the lateral SuM by carbachol, a cholinergic 
agonist, suppressed the CA1 population spike evoked with CA3 stimulation (Jiang 
and Khanna, 2006).  The population spike suppression was accompanied by theta 
generation in CA1, both of which were attenuated by inactivation of MS with 
intraseptal microinjection of the local anesthetic, procaine.  The intra-SuM carbachol-
evoked suppression of CA1 population spike was accompanied by the attenuation of 
the corresponding field EPSP indicating that SuM-septohippocampal input suppressed 
CA1 pyramidal cell synaptic excitability to Schaffer’s collateral stimulation (Jiang 
and Khanna, 2006).  Likewise, the SuM mediated the RPO stimulation-evoked 
suppression of CA1 pyramidal cell synaptic excitability to CA3 stimulation (Jiang and 
Khanna, 2004).  Here it is notable that inactivation of the medial SuM, but not lateral 
SuM, with the inhibitory ligand, GABA, abolished the RPO-elicited suppression of 
CA1 population spike (Jiang and Khanna, 2004).  Furthermore, such microinjection 
into the mSuM abolished the RPO stimulation-evoked generation of hippocampal 
theta wave activity (Jiang and Khanna, 2004).  Whereas, the microinjection of GABA 
into lateral SuM attenuated, but not abolished, the power of theta wave activity.  
Taken together, the foregoing suggests the possibility that the neurons in SuM are 
organized in a modular fashion along the mediolateral axis such that the medial SuM 
is more prominent in the mediation of reticularly-elicited changes in field CA1 of the 
hippocampus (Jiang and Khanna, 2006).   
 
As such, the recruitment of neurons in medial SuM is hypothesized to transduce 
relevant afferent information, especially on sensory and reticular stimulation, into a 
theta-frequency coded signal that is then transmitted to hippocampus via the MS (Pan 
and McNaughton, 2004).  In this regard, in vivo extracellular recordings performed on 
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anaesthetized rat indicate that the SuM neurons discharge phase-locked to concurrent 
hippocampal CA1 field theta (Kirk and McNaughton, 1991; Kocsis and Vertes, 1994; 
Bland et al., 1995; Kirk et al., 1996).  Interestingly, during high frequency theta 
elicited by sensory stimulation or during accelerating theta epochs, SuM neurons may 
discharge ahead of dentate theta peak with a constant time lag (Kocsis, 2006; Kocsis 
and Kaminski, 2006) suggesting that under such conditions the theta related neural 
activity in SuM can precede that in the hippocampus.  Conversely, during lower 
frequency theta, dentate theta peaks preceded SuM neuronal discharges, whereas MS 
neuronal discharge was ahead of theta peaks thereby suggesting a possible 
bidirectional loop within the SuM-septohippocampal network.   
 
Crucially, however, inactivation of the MS with local microinjection of the local 
anesthetic, procaine does not attenuate the theta-rhythmic discharge of SuM neurons 
even though such microinjection abolished hippocampal theta (Kirk et al., 1996).  On 
the other hand, procaine microinjected into the mSuM, and posterior hypothalamus in 
general, attenuated both RPO stimulation-induced theta rhythmic discharge of MS 
neurons and the power and frequency of the hippocampal theta (Kirk and 
McNaughton, 1993; Bland et al., 1994; Oddie et al., 1994).  In comparison, 
inactivation of sites rostral to the SuM with procaine affected only theta power, but 
not theta frequency (Kirk and McNaughton, 1993).  Similarly, microinjection of 
chlordiazepoxide, a positive allosteric modulator of GABAA receptor function, into 
the mSuM attenuated both the power and frequency RPO-evoked hippocampal theta 
in anaesthetized rat (Kirk and McNaughton, 1993; McNaughton et al., 1995).  
Chlordiazepoxide presumably attenuated neural activity in SuM via its action on the 
benzodiazepine-GABA-chloride ionophore complex to potentiate the effect of 
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endogenous GABA released into the synaptic cleft in the region.  This is in contrast 
with the effect of exogenous administration of GABA that attenuated only the power 
of the RPO stimulation-evoked hippocampal theta.  The restricted effect of GABA is 
likely due to its mode of action that presumably involved the enhancement of only the 
tonic, but not rhythmic inhibition impinging onto neurons in the mSuM and thus 
affecting the population size but not the rhythm generation on RPO stimulation (Jiang 
and Khanna, 2004).   
 
Manipulation of the SuM also affects theta generation in some behavioral paradigms.  
For example, microinjection of chlordiazepoxide into the mSuM or lesion of the SuM 
with the excitotoxic drug AMPA attenuated theta frequency during bar pressing seen 
in the fixed interval schedule paradigm in behaving rat (Pan and McNaughton, 1997; 
Pan and McNaughton, 2002; Woodnorth and McNaughton, 2002).  The decrease was 
observed even though the frequency of bar pressing was either increased or unaffected 
with drug microinjection and lesion, respectively.  However, lesion of the SuM do not 
affect theta generation in a number of other behavioral paradigms such as open field 
ambulation and differential reinforcement of low rates of response schedule 
(Thinschimdt et al., 1992; Pan and McNaughton, 2002).  The corresponding 
behavioral readout was either unaffected or enhanced by lesion, but not decreased.    
 
1.4 Cholinergic neurotransmission  
 
This chapter is focused on cholinergic neurotransmission in context of the SuM-
septohippocampal network.  While very few studies have explored the role of 
cholinergic neurotransmission in the medial septum and the SuM region, the 
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cholinergic neurotransmission in the hippocampus has been extensively investigated.  
For that reason, the following review of the literature is biased towards the 
hippocampus.   
 
1.4.1 Cholinergic markers 
 
Broadly, immunocytochemical and molecular biology techniques have identified the 
presence of markers of cholinergic neurotransmission in the SuM and the various 
regions linked with it.  For example, immuohistochemistry and in situ hybridization 
with digoxigenin tagged antisense mRNA probe have revealed the presence of the 
acetylcholine synthesizing enzyme, ChAT and/or the corresponding mRNA in the 
SuM, lateral hypothalamus, LDTg, the pedunculopontine tegmental nucleus (PPTg) 
and the medial septum.  The hippocampus is void of positive staining for ChAT 
(Armstrong et al., 1983; Tago et al., 1987; Oh et al., 1992; Lauterborn et al., 1993).  
Similarly, the enzyme acetylcholinesterase (AChE) that metabolizes acetylcholine is 
present in the SuM region (Parent and Butcher, 1976).  Interestingly, within the SuM, 
both ChAT and AChE are observed predominantly in the soma and proximal 
processes of medium sized neurons of the lateral SuM, while the small sized medial 
SuM neurons were not as intensely labeled.   
 
In line with the above, both cholinergic nicotinic and muscarinic receptors are 
observed in the SuM (Rotter et al., 1979; Wada et al., 1989; Le Novere et al., 1996).  
Thus, transcripts for a variety of nicotinic receptor subunits are localized in the SuM 
and the adjacent posterior hypothalamus.  The transcripts include alpha3, alpha4 and 
alpha6.  On the other hand, the neurons of the hippocampus and the MS mainly 
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expressed the transcripts for alpha7, alpha4 and beta2 subunits.  Here it is notable that 
ligand binding studies indicate that the two major types of nicotinic receptors in the 
CNS are formed by heteromeric assembly of the alph4 and the beta2 subunits and the 
homomeric assembly of alpha7 subunits.  In context of the latter, an earlier binding 
study using the nicotinic receptor antagonist at the alpha7 subunit, -bungarotoxin, 
reported that ligand bound mostly to GABAergic interneurons in the hippocampus 
(Freedman et al., 1993).  Likewise, single-cell reverse-transcription polymerase chain 
reaction (RT-PCR) and double in situ hybridization showed that a good number of the 
GABAergic interneurons in the hippocampus expressed the alpha7 and beta2 receptor 
subunits.  The alpha4 and other receptor subunits were less prevalent (Sudweks and 
Yakel, 2000; Son and Winzer-Serhan, 2008).  As such, the alpha4 transcript is 
detected at moderate levels in the CA fields and was not observed in the granular 
layer of the DG (Wada et al., 1990).  In addition, the alpha7 receptor subunits have 
also been located in the pre- and post-synaptic compartments at the glutamatergic and 
the GABAergic synapses (Fabian-Fine et al., 2001).  It is notable that while the beta2-
4 subunits are detected in pyramidal neurons, nicotinic receptor mediated postsynaptic 
currents are generally not detected in this class of neuron (Jones and Yakel, 1997; 
Sudweeks and Yakel, 2000).   
 
Although radiographic binding studies using the synthetic muscarinic receptor agonist 
propylbenzilylcholine points to the presence of muscarinic receptors in the SuM 
(Rotter et al., 1979), little is known about the distribution of the different muscarinic 
receptor subtypes in the region and also the surrounding posterior hypothalamic 
region.  In the medial septum, the septohippocampal projection neurons were found to 
predominantly express the muscarinic M2 and M3 receptor-proteins (Rouse and 
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Levey, 1996).  The receptors, detected by immunohistochemical means, were 
expressed in the cell body and the proximal axonal and dendritic processes.  Indeed, 
the m2 receptor-protein was also found co-localized with the vesicular acetylcholine 
transporter (VAT) at the cholinergic axon terminal in the hippocampus (Rouse et al., 
1999) and modulated the release of acetylcholine in a negative feedback fashion.  For 
example, in in vitro experiments, the cholinergic agonist, oxotremorine, inhibited 
potassium induced ACh release in a hippocampal slice preparation from a wild type 
animal.  The inhibitory effect of oxotremorine was prevented by knockout of M2 
protein (Zhang et al., 2002).  Overall, however, lesions of the fimbria-fornix reduced 
the level of hippocampal m2 expression by only 25%, implying that a majority of M2 
was intrinsic to the hippocampus or from non-septal origins (Levey et al., 1995; 
Rouse et al., 1999).  Within the hippocampus, the m2 receptor-protein was observed 
both in GABAergic axon terminals that formed a basket like structure surrounding the 
pyramidal cells, and postsynaptically in GABAergic interneuron, especially in the 
stratum oriens of the field CA1 and CA3 (Levey et al., 1991, 1995; Hajos et al., 
1998).  Among the other muscarinic receptor-proteins, the m1 muscarinic receptor-
protein was observed as fine puncta in the somatic region of the principal cells and at 
the apical and basal dendritic tree in the hippocampus (Levey et al., 1995).  The 
authors also described the distribution of the m3 and m4 muscarinic receptor-proteins.  
The m3 immunoreactivity was observed predominantly in the stratum lacunosum-
moleculare of field CA1, the immunoreactivity being present as a network of fibers 
and puncta.  The m4 was expressed in the dendrites of stratum oriens neurons and in 




1.4.2 Neural effects 
 
Given the foregoing, it is not surprising that both nicotinic and muscarinic receptor 
mediated neural effects have been observed in the hippocampus, although at present 
there is paucity of information regarding the neural effect(s) of cholinergic 
neurotransmission in the SuM region.  However, broadly, it has been suggested that 
cholinergic muscarinic receptors in the posterior hypothalamus play a role in theta 
activation (Bland et al., 1994; see ‘Cholinergic modulation of hippocampal 
information processing’ below).  Furthermore, microinjection of the cholinergic 
agonist carbachol or the cholinesterase inhibitors, neostigmine and physostigmine, 
into the region increased the mean arterial blood pressure in the rat (Buccafusco and 
Brezenoff, 1979).  The autonomic effect was mediated by the muscarinic receptors as 
prior injection of atropine or muscarinic receptor subtype selective antagonist, but not 
the nicotinic antagonist, mecamylamine, blocked the increase in blood pressure 
(Buccafusco and Brezenoff, 1979; Martin, 1992). 
 
In the medial septum, a tonic cholinergic tone was shown to excite septal GABAergic 
neurons in vitro.  In this context, atropine or scopolamine applied into the bath 
medium reduced the basal firing rate of these neurons (Alreja et al., 2000; Wu et al., 
2000).  This excitation was mediated by the M3 muscarinic receptor, at least in part, 
as bath application of 4-DAMP mustard, the M3 receptor antagonist, also reduced the 
basal firing rates of the GABAergic neurons, mimicking the effect of atropine and 
scopolamine.  Interestingly, application of muscarine to the bath medium had no 
effect (37%) or inhibited (63%) identified cholinergic neurons (Wu et al., 2000).  This 
inhibitory response of muscarine was blocked in presence TTX, suggesting that the 
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inhibitory effect was mediated via an action potential dependent release of inhibitory 
transmitter, presumably via excitation of GABAergic neurons in the region.  
 
In context of the hippocampus, cholinergic stimulation increases the postsynaptic 
excitability of CA1 pyramidal cells (Halliwell and Adams, 1982; Segal, 1982; Cole 
and Nicoll, 1983; Benson et al., 1988; Halliwell, 1990; Shinoe et al., 2005).  The 
hallmarks of the increase are: (a) membrane depolarization that may be accompanied 
by increase in cell membrane resistance and is antagonized by m1 receptor 
antagonized, pirenzipine, knockout of m1 receptor and tetraethylammonium, a 
potassium channel blocker; (b) impairment of adaptation during repetitive spike firing 
to depolarizing pulse; and (c) suppression of slow after-hyperpolarization evoked in 
response to a brief depolarizing pulse.  The increase in excitability may be linked, at 
least in part, to block of potassium current.  In this regard, application of muscarine 
and carbachol in bath medium abolishes potassium mediated and depolarization-
induced outward going current recorded using voltage clamp technique (Halliwell and 
Adams, 1982).   
 
Cholinergic stimulation also evokes disinhibition.  Consistent with cholinergic 
mediated disinhibition, both medial septal stimulation and iontophoretic application of 
acetylcholine in vivo attenuated the IPSPs evoked in CA1 pyramidal cells on afferent 
stimulation (Ben-Ari et al., 1981; Krnjevic et al., 1981; Krnjevic et al., 1988).  
However, such application of acetylcholine did not affect the postsynaptic 
hyperpolarization evoked in pyramidal neurons by the inhibitory ligand GABA 
applied iontophoretically near the pyramidal cell body recording site.  This suggested 
that the attenuation of IPSPs by acetylcholine was by a presynaptic mechanism.  In 
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line with this, bath application of the cholinergic agonist, carbachol depressed the 
frequency, but not amplitude of miniature IPSCs in an atropine-sensitive fashion, 
indicating a role for hippocampal muscarinic cholinergic receptors in mediating the 
decreased release of the inhibitory transmitter (Pitler and Alger, 1992; Behrends and 
ten Bruggencate, 1993).  The application of the agonist also blocked stimulation-
evoked IPSP (eIPSP) in CA1 pyramidal cells in vitro while enhancing the paired-
pulse facilitation of IPSP (Pitler and Alger, 1992; Behrends and ten Bruggencate, 
1993; Kim et al., 2002; Fukudome et al., 2004).  The latter is consistent with 
presynaptic inhibition of synaptic transmission by the cholinergic agonist.  
Interestingly, the inhibitory effect of carbachol on eIPSP was either sensitive to 
antagonism by the M2 receptor antagonist, gallamaine, or insensitive to the antagonist 
(Fukodome et al., 2004).  The latter type of eIPSP was antagonized by cannabinoid 
receptor antagonist and by knockout of m1 or cannabinoid receptors (Kim et al., 
2002; Fukodome et al., 2004).   
 
On the other hand, iontophoretic application of atropine to putative inhibitory 
interneurons in field CA1 in vivo reduced their activity during theta rhythm 
suggesting that these interneurons are excited by cholinergic mechanisms, at least in 
part, under physiological conditions (Stewart et al., 1992).  Furthermore, in vitro 
studies indicate that application of cholinergic agonists excite GABAergic inhibitory 
interneurons, both by muscarinic and nicotinic receptor mechanisms, and increase the 
frequency and amplitude of IPSPs/IPSCs impinging on hippocampal pyramidal cells 
(Reece and Schwartzkroin, 1991; Pitler and Alger, 1992; Behrends and ten 
Bruggencate, 1993; Jones and Yakel, 1997; Alkondon et al., 1999; Chapman and 
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Lacaille, 1999; McQuiston and Madison, 1999; Buhler and Dunwiddie, 2002; Reich 
et al., 2005).   
 
As with the effect on inhibitory neurotransmission, cholinergic neurotransmission has 
paradoxical effects on excitatory neurotransmission in hippocampus.  Thus, both the 
stimulation of the medial septum and the application of acetylcholine in apical 
dendrites reduced the apical dendritic field EPSP of the CA1 pyramidal cells that was 
antagonized by co-administration of the muscarinic antagonist, atropine (Rovira et al., 
1983).  The dendritic application of acetylcholine did not affect postsynaptic 
depolarization evoked in pyramidal neurons by brief application of glutamate in the 
apical dendrites suggesting that the transmitter attenuated pyramidal cell excitation 
via a presynaptic mechanism, at least in part (Valentino and Dingledine, 1981).  In 
line with this, carbachol reduced the frequency of miniature EPSPs (mEPSPs) 
recorded from CA1 pyramidal cells in hippocampal slices (Seeger and Alzehimer, 
2001).  However, a decrease in amplitude of mEPSPs was also observed suggesting 
postsynaptic effect of the drug as well.  Accordingly, dendritic application of 
carbachol induced a decrease in the amplitude of the EPSP-like waveform evoked on 
administration of exogenous glutamate in presence of TTX (Seeger and Alzheimer, 
2001).  The postsynaptic effect was linked to the facilitation of inward potassium 
current that shunted the EPSP (Seeger and Alzheimer, 2001).  This is unlike the effect 
on soma where cholinergic agonists blocked an outward potassium current (see 
above). 
 
Similar to the effect on eIPSP (see above), the cholinergic-mediated inhibition of 
excitatory synaptic transmission involves both the m2 and the m1 receptors.  Thus, 
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the inhibitory effect of carbachol on both the frequency and amplitude of mEPSP, and 
also the suppression of glutamate-induced EPSP in presence of TTX, is reversed by 
co-administration of the m2 receptor antagonist, gallamine (Seeger and Alzheimer, 
2001).  Moreover, cholinergic agonist-mediated inhibition of release of acetylcholine 
from hippocampal slices and synaptosomes is attenuated on knockout of the M2 
receptor or by administration of putative M2 antagonist (Marchi and Raiteri, 1989; 
Gulya et al., 1989; Zhang et al., 2002).  In context of the role of m1 receptor, the 
suppression of apical dendritic field EPSP by cholinergic agonist is attenuated in the 
hippocampal slices taken from m1, but not m3 knockout mice (Shinoe et al., 2005; 
Kremin et al., 2006).  In parallel, the paired-pulse facilitation of synaptic transmission 
by muscarinic agonist(s) is also attenuated.   
 
Unlike muscarinic agonists, nicotinic receptor agonists such as 
dimethlyphenylpiperazine (DMPP) applied in the apical dendrites enhanced the 
dendritic field EPSP (Rovira et al., 1982).  Interestingly, pressure puff application of 
nicotine onto the dendritic compartment of CA3 pyramidal cells increased calcium 
influx into the presynaptic terminals of mossy fibers as detected by Fura2 signals 
(Gray et al., 1996).  Accordingly, a nicotinic receptor-mediated increase in the 
frequency, but not amplitude of miniature excitatory post synaptic currents is 
observed in CA3, and also in CA1 pyramidal cells suggesting a presynaptic mediated 
increase in excitatory transmitter release on cholinergic-nicotinic activation (Gray et 
al., 1996; Ji et al., 2001).  Along this line, ACh applied via pressure puff to CA1 
proximal dendrites evoked mecamylamine sensitive postsynaptic currents in CA1 
pyramidal cells in presence of atropine (Ji et al., 2001).   
 
 38 
1.4.3 Cholinergic modulation of hippocampal information processing 
 
Some of the effects of cholinergic neurotransmission that are described above have 
been linked with hippocampal information processing.  Indeed, the data suggest a 
cholinergic link along the posterior hypothalamus-septohippocampal axis.  In context 
of the posterior hypothalamus, cholinergic transmission through the region influences 
reticular stimulation-induced theta activity in the hippocampus.  Thus, microinjection 
of atropine into the posterior hypothalamus abolished hippocampal theta and the 
concurrent rhythmic discharge of septal theta cells induced by electrical stimulation of 
the pontine region (Bland et al., 1994; Bocian and Konopacki, 2004).  Similarly, 
microinjection of the M1 receptor antagonist, pirenzepine, abolished reticular 
stimulation evoked hippocampal theta in the freely moving cat (Bocian and 
Konopacki, 2004).  No effect on hippocampal theta frequency and amplitude was 
observed with the M2 receptor antagonist gallamine and the nicotinic receptor 
antagonist hexamethonium.   
 
In turn, the septohippocampal cholinergic neurons modulate hippocampal neural 
activity during theta activation such that destroying the septal cholinergic neurons 
and/or antagonizing cholinergic synaptic transmission in the hippocampus attenuated 
the power of theta wave activity, reduced interneuronal discharge and the suppression 
of Schaffer collateral-induced synaptic transmission at apical dendrites and attenuated 
the facilitation of synaptic transmission at basal dendrites (Leung et al., 1994; Zheng 
and Khanna, 2001; Leung and Peloquin, 2009). 
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The cholinergic receptor mechanisms also influence hippocampal synaptic plasticity.  
Thus, the afferent stimulation-induced LTP at CA1 pyramidal cell basal dendrites is 
enhanced during walking when septohippocampal cholinergic afferents are 
physiologically active as compared to the still-alert state of the animal (Leung et al., 
2003).  Indeed, the facilitation of LTP, over and above the LTP seen during still-alert 
state, was abolished by selective lesion of the septohippocampal cholinergic neurons 
or with intraventricular administration of the scopolamine or pirenzepine.   
 
In hippocampal slices, the Schaffer collaterals stimulation-induced LTP at apical 
dendrite is also facilitated by application of cholinergic agonist carbachol or by 
stimulation of cholinergic afferents in the stratum oreins (Shinoe et al., 2005).  In this 
study, carbachol was applied at concentration that did not influence basal synaptic 
response on Schaffer collateral stimulation.  Interestingly, the facilitation of LTP by 
carbachol or by stimulation of cholinergic afferents was abolished in m1 knockout 
mice which, however, did not affect the ability to generate LTP per se.  Indeed, 
acetylcholine puffed at the somatodendritic shaft of the CA1 pyramidal cell increased 
intracellular calcium signals and in parallel with the potentiation of the Schaffer 
collaterals stimulation induced LTP (de Sevilla et al., 2008).  This facilitation was 
blocked by the bath application of pirenzepine and not methyllycaconitine and 
methoctramine.  In this context, the potentiation of EPSCs was shown to be facilitated 
by an M1 receptor mediated release of internal calcium stores via the IP3 receptors as 
UV uncaging of IP3 produced similar LTP of evoked EPSCs.  Inhibition of increase in 
intracellular calcium by BAPTA, heparin and thapsigargin and not AP5 (to block 
influx of calcium via the NMDA receptors) blocked the LTP, suggesting that M1 
receptor mediated LTP is dependent solely on internal calcium stores.  Furthermore, 
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IP3 mediated LTP was action potential dependent as acetylcholine mediated LTP of 
the evoked EPSCs was not blocked by TTX.   
 
Interestingly, afferent stimulation-induced LTP at Schaffer collateral-CA1 synapse is 
abolished in the m2 knockout animal (Seeger et al., 2004).  This effect on LTP was 
linked to facilitation of inhibitory transmission following m2 knockout as LTP was 
restored in the presence of bicuculline.  Apart from muscarinic receptors of the 
hippocampal pyramidal cells, the nicotinic cholinergic receptors are also involved in 
facilitating LTP of evoked potentials.  In this context, dendritic puff application of 
acetylcholine, in the presence of atropine, facilitated the switch from short term 
potentiation (STP) to LTP of Schaffer’s collateral stimulation evoked EPSPs (Ji et al., 
2001).   
 
1.5 c-Fos expression in the hippocampus 
 
c-Fos, which is a nuclear protein product of the immediate early gene (IEG) c-fos, can 
be induced in hippocampal neurons under different situations and, in general, serves 
as a marker of trans synaptic neuronal activation and molecular plasticity (Hunt et al., 
1987; Sagar et al., 1988).  In general, the induction of c-Fos occurs via multiple 
upstream mediators including diacylglycerol (DAG), cyclic AMP (cAMP), Janus 
activated kinases (JAK) and intracellular calcium (He and Ping, 2009).  Production of 
DAG and cAMP leads to activation of protein kinases A and C, respectively, while 
activation of JAK via cytokine receptor activation leads to the phosphorylation and 
homodimerisation of the signal transducer and activator of transcription (STAT) 
factors.  Increase in intracellular calcium via calcium calmodulin activates CaM 
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kinases resulting in phosphorylation of downstream effector proteins such as the 
serum response factor or CREB.  These factors then interact with the serum response 
element (SRE), sis-inducible enhancer (SIE) or cyclic AMP response element (CRE).  
SRE, SIE and CRE are located upstream of the c-fos gene and acts as a promoter to 
activate c-fos and the subsequent synthesis of c-fos mRNA before translation into c-
Fos protein (Sheng and Greenberg, 1990; Ghosh et al., 1994; Karin et al., 1997).  c-
Fos protein heterodimerises with Jun, also a member of the IEG family, via the 
leucine zipper binding domain to form a activator protein-1 (AP1), a transcription 
factor which is involved in the regulation of late effector genes (Hess et al., 2004). 
 
The induction c-Fos was first shown in an in vitro setup.  Incubation of differentiated 
PC12 cells expressing muscarinic and nicotinic cholinergic receptors with nicotine for 
15 minutes resulted in an increase in c-fos mRNA as detected by Northern blot 
analysis (Dichter, 1977; Amy and Bennet, 1983; Greenberg et al., 1986).  The 
increase in c-fos mRNA levels in the cells was calcium dependent as addition of 
EGTA, a calcium chelator, into the incubation medium inhibited the elevation of c-fos 
mRNA levels.  Similarly, stimulation of glutamate receptors on cultured cortical 
neurons induced expression of c-fos mRNA which was again detected on a Northern 
blot.  Induction of c-fos mRNA was blocked by AP5, indicating that NMDA receptors 
were involved (Ghosh et al., 1994).  However, using transfection assays, it was shown 
that activation of calcium and glutamate channels activate different intra-cellular 
pathways even though the activation of c-fos was the primary downstream effect 
(Ghosh et al., 1994).  c-fos activation via voltage gated calcium channels was 
dependent on CRE while activation of NMDA receptors induce c-fos mRNA 
expression via the SRE.   
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In vivo, the neural expression of c-Fos, especially in the hippocampus, is low under 
basal conditions unlike some of other IEG products such as Krox24 and Jun (Hughes 
et al., 1992).  However, the hippocampal level of c-Fos is increased by a variety of 
stimuli.  For example, lowering a needle into the hippocampus elevated c-Fos protein 
expression in the blades of the ipsilateral dentate gyrus compared to the contralateral 
hippocampus (Dragunow et al., 1990).  Pretreatment with MK801, an NMDA 
receptor inhibitor, suppressed c-Fos expression.  Similarly, c-Fos expression in 
hippocampus, including field CA1-CA3 and dentate gyrus, is increased with mild 
stress such as injection of intraperitoneal hypertonic saline, injection of saline into the 
hind paw or mild foot shock (Sharp et al., 1991; Smith et al., 1992; Melia et al., 1994; 
Cullinan et al., 1995; Ryabinin et al., 1995; Emmert and Herman, 1999; Khanna et al., 
2004; Ons et al., 2004; Pace et al., 2005).  Novelty potently induces c-fos and the 
corresponding protein in the hippocampus, especially in the hippocampal field CA1 
(Hess et al., 1995; Kerr et al., 1996; Wan et al., 1999; Pace et al., 2005; Wirtshafter, 
2005).  Novelty evoked c-Fos in CA1 is reflective of hippocampal information 
processing and is graded and varies with the degree of novelty.  In this context, the 
density of immunostained c-Fos positive neurons in the hippocampal field CA1, 
increases with exposure to environments of increasing novelty (Sheth et al., 2008; 
VanElzakker et al., 2008).  Interestingly, pharmacological agents, such as the 
muscarinic agonist, pilocarpine, administered systemically also enhanced the levels of 
c-fos, along with the corresponding protein, in CA1.  On the other hand, systemic 
administration of the cholinergic antagonist attenuated both agonist- and novelty-
induced expression of c-Fos in CA1 (Hughes and Dragunow, 1993; Wirtshafter, 
2005).   
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Hippocampal c-fos and the associated protein may affect excitability of neurons and 
synaptic plasticity.  In this context, it was recently shown that the size of the lesion in 
CA3 induced with systemic administration of the glutamate agonist, kainic acid, was 
increased in c-fos knockout (KO) mice (Zhang et al., 2002).  This was accompanied 
by an increase in basal expression of GluR6 glutamate receptor subunit and a reduced 
expression of brain-derived neurotrophic factor (BDNF) protein.  Conversely, in vivo 
transfection of mouse neuroblastoma and human glioblastoma cell lines with a viral 
plasmid to induce an increase in c-Fos mRNA expression led to an attenuation of 
GluR6 and an increase in BDNF mRNA expression.  GluR6 is involved in excitatory 
neurotransmission while BDNF serves as a neuroprotective neurotrophic factor, for 
example during seizures.  Indeed, intracerebroventricular infusion of BDNF 
antisesnse oligodeoxynucleotide resulted in an increase in kainic acid induced seizure 
duration and the resultant neuronal cell loss in hippocampal field CA1 (Tandon et al., 
1994).  Taken together, this suggests that c-Fos is able to modulate both hippocampal 
cellular excitability and protect neurons from potential excitotoxicity via a 
suppression of GluR6 and potentiation of BDNF expression, respectively.   
 
Moreover, c-fos facilitates hippocampal LTP and the consolidation of long-term 
memory in behavioral experiments (Fleischmann et al. 2003).  Compared to wild type 
mice, c-fos KO animals had memory deficits during the probe trial of the water maze 
test as mutant animals were not able to identify the quadrant containing the hidden 
platform.  Also, in a contextual fear conditioning paradigm, KO animals did not 
exhibit freezing behaviors compared to wild type animals upon re-exposure to the 
conditioning chamber where foot shocks were previously administered.  These 
behavioral results suggested that c-fos is essential for hippocampal dependent 
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learning.  Furthermore, in a hippocampal slice preparation, CA1 EPSP evoked by 
CA3 stimulation showed impaired LTP following CA3 tetanic stimulation (Guzowski, 
2002; Fleischmann et al. 2003).   
 
1.6 Rationale and purpose of study 
 
As reviewed in the previous sections, anatomical and electrophysiological evidences 
support a role for cholinergic mechanism in the SuM region in modulating 
hippocampal function.  Firstly, the SuM is immunoreactive for markers of cholinergic 
neurotransmission, namely: (a) ChAT, a marker for cholinergic neurons (Tago et al., 
1987; Armstrong et al., 1983), (b) AChE, a marker for cholinergic terminals (Parent 
and Butcher, 1976) and (c) cholinergic receptors, including both nicotinic and 
muscarinic receptors (Wada et al., 1989; Rotter et al., 1979).  Secondly, in vivo 
recordings in anaesthetized rat show that microinjection of the cholinergic agonist, 
carbachol, into the SuM elicits hippocampal theta and a concurrent suppression of 
CA1 population spike (Jiang and Khanna, 2006).  This pattern of neural change 
mimics that seen with behavioral arousal and, indeed, the SuM is recruited by the 
pontine nucleus rostral pontine oralis (RPO) which is implicated in behavioral 
arousal.  In this regard, inactivation of the RPO evokes anesthetic-like effect (Devor 
and Zalkind, 2001) while stimulation of region elicits hippocampal theta activation 
and suppression of CA1 both of which are mediated by the SuM (Kocsis and Vertes, 
1994; McNaughton et al., 1995; Bland and Oddie, 1998; Kirk, 1998; Pan and 
McNaughton, 2004; Jiang and Khanna, 2004).  Moreover, inactivation of the SuM 
attenuates hippocampal theta activation which is in parallel with decrement in animal 
arousal and behavioral activation, and behavioral inhibition to aversive stimuli (Bland 
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and Oddie, 2001; Ma et al., 2002; Pan and McNaughton, 2002; 2004; Ma and Leung, 
2006).   
 
Interestingly, the peripheral application of a noxious stimulus in the form of formalin 
injection into the hind paw also elicits theta activation and suppression of CA1 PS 
(Khanna; 1997).  However, it remains unclear whether nociceptive activation with 
formalin recruits the SuM as part of an ascending relay to the CA1 and share a 
common cholinergic base within SuM with reticular stimulation.  To test this out, the 
following experiments were carried out:   
 
(a) investigation of the effects of SuM microinjection of cholinergic antagonists 
on CA1 responses elicited by the following: 
a. intra-SuM carbachol,  
b. reticular (RPO) stimulation, and  
c. noxious-stimulation with hind paw injection of formalin 
 
(b) investigation of the topographic nature of the nociceptive relay with intra-SuM 
microinjection of the cholinergic antagonists, and 
 
(c) investigation of the spatial pattern of activation of neurons in the hippocampus 
and dentate gyrus with intra-SuM carbachol.  In these experiments, the neural 
expression of the transcription protein, c-Fos, was used as marker of neural 


























2.1 Animals and general procedures 
 
Experiments were performed on Sprague-Dawley rats obtained from the Laboratory 
Animal Centre, National University of Singapore, Singapore.  The animals were 
anaesthetized with urethane (Sigma, USA, 1g/kg i.p.), mounted onto a stereotaxic 
frame and burr holes drilled on the exposed skull at the selected stereotaxic 
coordinates to facilitate electrophysiological recording and electrical and/or chemical 
stimulation of the targeted brain regions.  All experimental procedures were approved 
by the Institutional Animal Care and Use Committee (IACUC) at the National 
University of Singapore.   
 
2.2 Electrophysiological procedures 
 
2.2.1 Extracellular recording  
 
To record extracellular field potentials, a carbon fiber microelectrode was lowered 
into the pyramidal cell layer of the left hippocampus at an angle of 12 degrees to the 
vertical to target dorsal field CA1 (P4.0 mm, L2.5 mm from midline, V 2.0-3.0 mm 
from cortical surface; Paxinos and Watson, 1997).  As previously documented (Jiang 
and Khanna, 2004; 2006), the signal from the carbon fiber was amplified and filtered 
at i) 1-100Hz to record local hippocampal EEG, and ii) 1-3000Hz to record 
population spike (PS) in the pyramidal CA1 layer.  The PS was generated by 
stimulation of the ipsilateral CA3 region (0.1Hz, 0.01ms pulse duration; P3.0 mm, 
L1.5-2.0 mm, V4.0 mm; Paxinos and Watson, 1997) with a concentric bipolar 
electrode (Model NE-100, David Kopf, USA) through a constant current stimulation 
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isolation unit (Grass Instruments, USA)  Generally, the stimulus voltage was adjusted 
to evoke 70% of maximal PS amplitude.   
 
2.2.2 Intracerebral stimulation 
 
To generate hippocampal theta wave activity (Jiang and Khanna, 2004), the region of 
the rostral reticularis pontine oralis (RPO; P8.0, L0.8, V9.0 from cortical surface) was 
stimulated every 10 sec for duration of 2.56s with a train of electrical pulses (0.01ms 
duration at 100Hz) using a stainless steel concentric bipolar electrode (Model NE-
100, David Kopf, USA).  The RPO stimulation was, in some experiments, paired with 
single pulse CA3 stimulation applied at interval of 10ms from the end of RPO tetanus.  
The strength of CA3 stimulus was adjusted to evoke CA1 PS that was 70% of 
maximal recorded during a period of large irregular EEG activity (or large irregular 
activity, LIA).  The RPO stimulation voltage was adjusted to evoke theta wave 
activity at about 4-5Hz frequency (T volt stimulation).  RPO stimulation also evoked 
a suppression of the paired CA1 PS (Jiang and Khnana, 2004).  In some experiments 
the RPO stimulation voltage was adjusted to T-1 volt and T+1 volt.  T-1 volt 
stimulation resulted in PS suppression alone.  The suppression at T-1 volts is 
submaximal whereas T and T+1 volt stimulation are supramaximal for PS suppression 









The drug(s) were microinjected either using a double barreled silicon cannula 
assembly or via a single 33G microinjection needle coupled to an Exmire syringe (Ito 
Corporation, Japan).   
 
The double barreled assembly was used for pharmacological investigations with 
microinjection of combination of an agonist and an antagonist into the SuM region 
(and the PH and the contiguous VTA; see the section immediately below).  The 
double barrel silicon cannula assembly was made by fusing two 33G silicon cannula 
(WPI, USA) and was directed at an angle of 12 degrees to the vertical and 1.5 to 2.0 
mm lateral from midline on the contralateral side (right sight) towards the ipsilateral 
SuM region (P4.5 mm, L1.5 mm to 2.0mm, V9.5 mm from cortical surface; Paxinos 
and Watson, 1997).  The double barrel had a total external diameter of 100µm.  A 
polyethylene tubing (Portex, UK) was attached to the external end of each silicon 
cannula.  The other end of the tubing was connected to an Exmire microsyringe (Ito 
Corporation, Japan) which was used to microinject discrete volumes (0.1l).  The two 
barrels of the cannula were oriented along the rostral-caudal axis.  The anterior 
cannula was filled with carbachol (0.85mM, Sigma, USA; Jiang and Khanna, 2006) or 
the glutamate receptor agonist, L-glutamic acid (0.05mM, Sigma, USA).  The 
posterior cannula contained solution of either the cholinergic-nicotinic antagonist, 
mecamylamine hydrochloride (10mM, Sigma, USA; Ikemoto et al, 2006) or the 
cholinergic-muscarinic antagonist, atropine sulphate (0.01mM, Sigma, USA).  All 
drugs above were dissolved in Alcian blue dye-saline (0.5% w/v, Sigma, USA).  The 
concentration of atropine and glutamate was determined in a pilot study.  In that 
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study, various concentrations of atropine and glutamate were used to determine a low 
concentration required to antagonize carbachol induced hippocampal responses and 
mimic carbachol-like effects on hippocampal theta and PS suppression, respectively 
(Jiang and Khanna, 2006).   
 
The single 33G needle was used to microinject cholinergic agonists or antagonists 
into the SuM region.  Such microinjection was performed in experiments involving 
intracerebral stimulation, sensory stimulation or c-Fos mapping of network activation.   
 
2.4 Experimental protocol 
 
2.4.1 Pharmacological investigations with drug microinjection into SuM 
 
These experiments were performed so as to investigate the nature of the cholinergic 
receptor(s) in the SuM (including the PH and VTA) that underpin the effect of local 
microinjection of the cholinergic agonist, carbachol, on hippocampal responses.  
During the experiment, the receptor agonist (i.e. carbachol or L-glutamic acid) was 
microinjected after 5mins of PS recording during the period of LIA.  The size of the 
control PS (prior to microinjection) was adjusted to about 70% of maximal.  After 
each microinjection, hippocampal responses were recorded for 20mins and again for 




 min.  Each experiment comprised of 5 microinjections of the 
agonist, 1hr apart.  Mecamylamine or atropine was microinjected once 5mins before 
the 3
rd
 microinjection of the agonist, under LIA.  The protocol adopted is depicted in 






Fig 2.1  The protocol used to investigate the effect of mecamylamine (Mec), a 
nicotinic cholinergic receptor antagonist and atropine (Atro), a muscarinic cholinergic 
receptor antagonist on (A) intra-SuM carbachol (Carb) or glutamate (Glu) 
microinjection - , (B) reticular (RPO) stimulation - or (C) formalin - induced 
hippocampal responses.  The numbers below each vertical tick along the horizontal 
line represents the time point with respect to the microinjection of Carb/Glu (A) or 
Mec/Atro (B and C) into the SuM, which is taken to be 0min.  In all cases, CA1 field 
potential evoked by ipsilateral CA3 stimulation (single pulse; 0.01ms; 0.1Hz) was 
first recorded under large irregular activity (LIA) of the hippocampal 
electroencephalogram (EEG).  The stimulation intensity was adjusted to evoke 70% 
of the maximum PS amplitude.   
 
In (A), the effect of carbachol (0.1µl, 0.85mM) on hippocampal responses was paired 
with Mec (0.1µl, 10mM) or Atro (0.1µl, 0.01mM).  Mec and Atro were dissolved in 
0.5% w/v Alcian blue dye.  The drugs were microinjected using a double barrel 
cannula.  The double barrel cannula was oriented along the rostro-caudal axis of the 
SuM, with the anterior cannula filled with carbachol while the posterior cannula was 
filled with Mec or Atro.  Carbachol was microinjected 5 times into the SuM, 1 hour 
apart, 5mins from the start of recording the CA3 stimulation evoked CA1 population 
spike (PS) under LIA EEG (at time point 0min in (A), upper panel).  Hippocampal 
responses were monitored for a further 20mins and again for 1min at the 40
th
 (39 to 
40min) and the 60
th
 (59 to 60min) minute.  To determine the effect of Mec or Atro on 
carbachol evoked responses, Mec or Atro was microinjected 5mins before the 3
rd
 
microinjection of carbachol (-5min time point; A, lower panel).  Hippocampal 
responses evoked by the first two carbachol microinjections were averaged and 
plotted as ‘Control’.  Similarly, responses evoked by the 3rd, 4th and 5th carbachol 
microinjection were accordingly labeled as Mec – or Atro – C3, C4 and C5.   
 
To determine the receptor specificity of the effects of Mec or Atro, adopting the same 
protocol, L-glutamic acid or glutamate (Glu; 0.1µl, 0.05mM dissolved in saline) was 
microinjected instead of carbachol.  In this context, the evoked hippocampal 
responses were labeled as Mec – or Atro – G3, G4 and G5.   
 
The protocol adopted in investigating the effect of Mec or Atro on stimulation of the 
RPO (single pulse, 0.01ms, 100Hz) is depicted in (B).  RPO was stimulated 5mins (-
10min time point) after the recording of CA1 PS under LIA EEG (-15 to -10min time 
points).  At 0min, Mec or Atro was microinjected into the SuM via an Exmire 
microsyringe.  Hippocampal responses were subsequently recorded for 20mins and 




 minute.   
 
In (C), the protocol used to investigate the effect of Mec or Atro on formalin (0.05ml 
s.c., 5%) induced hippocampal responses is shown.  In this instance, after recording 
CA1 PS under LIA EEG (-10 to -5min time points), formalin was injected (-5min 
time point) into the plantar region of either the left or right hind paw in a counter 
balanced fashion.  Mec or Atro was microinjected into the SuM via an Exmire 
microsyringe 5mins after formalin (0min time point) and recorded for a further 


























































39 40 59 60 -5 0 20 
Carb / Glu  
CA3 stimulation 
(single pulse; 0.01ms; 0.1Hz) 
Mec / Atro 
 
Carb / Glu 
 
0 20 -5 -10 
CA3 stimulation 
(single pulse; 0.01ms; 0.1Hz) 
CA3 stimulus 
(single pulse; 0.01ms; 0.1Hz) 
-10 -5 0 20 
Formalin 
(5%; 0.05ml) 








(single pulse; 0.01ms, 100Hz) 
0 20 -10 -15 
CA3 stimulus 
(single pulse; 0.01ms; 0.1Hz) 
 






2.4.2 Investigation of the effect drug microinjection on intracerebral 
stimulation evoked CA1 responses  
 
These experiments were performed to determine whether cholinergic mechanisms in 
the posterior hypothalamic regions (SuM, PH and VTA) mediate reticularly (RPO)-
elicited theta activation and suppression of CA1 population spike.  During the 
experiment, CA1 PS was recorded under LIA activity for 5mins and then paired with 
RPO stimulation for 10mins before intra-SuM microinjection of mecamylamine or 
atropine.  Following microinjection, the effects of RPO stimulation was recorded 




 min (Fig 2.1).   
 
2.4.3 Investigation of the effect of drug microinjection on sensory stimulation 
evoked CA1 responses 
 
These experiments were performed to determine whether intra-SuM cholinergic 
receptor mechanisms modulate sensory stimulation-induced changes in field CA1.  
Sensory stimulation was applied in form of subcutaneous injection of formalin (5%, 
0.05ml) into the plantar surface of the right or the left hind paw.  The injections were 
made at least 3hr apart and were carried out in a counter-balanced fashion.  Hind paw 
formalin excites peripheral nociceptors and generates prolonged and robust theta 
activation and suppression of CA1 pyramidal cell excitability (Khanna, 1997).  As 
such, formalin injection provided a stable electrophysiological background against 




During experiments, the formalin was injected 2mins after basal recording of PS 
(70% of maximal) under LIA.  The cholinergic antagonist (either atropine or 
mecamylamine at the above noted concentrations) was microinjected into the SuM 
region 5mins later via a stainless steel cannula (33G, PlasticsOne, USA) connected 
via a polyethylene tubing (Portex, UK) to an Exmire syringe (Ito Corporation, Japan).  





 minute (Fig 2.1).   
 
2.4.4 Investigation of the effect of intra-SuM carbachol microinjection on 
hippocampal c-Fos expression 
 
These experiments were performed to investigate the effect of intra-SuM carbachol 
(0.1µl, 0.85mM) on expression of the immediate early gene protein c-Fos, in the 
hippocampus.  Carbachol was microinjected into the SuM via an Exmire microsyringe 
(Ito Corporation, Japan).  After directing the syringe towards the SuM (P4.2, L1.0, 
V8.5mm; Paxinos and Watson, 1997), the animal was left to recover for at least 3 
hours and spontaneous CA1 theta activity can be observed. Spontaneous theta is 
reflective of recovery from the lowering of the microinjection needle.  Prior to 
microinjection of carbachol, irregular EEG activity was recorded for 5mins.  
Following the microinjection of carbachol, hippocampal EEG was subsequently 






 minutes.  Animal was 








2.5.1 Nissl stain 
 
After each electrophysiology experiment, the animal was transcardially perfused with 
0.9% w/v sodium chloride (Merck, Germany) followed by 5% v/v formalin (Merck, 
Germany).  The brain was removed and immersed with the same fixative overnight.  
60µm coronal sections were made on a vibrotome (LeicaVT1200, Leica, USA) and 
collected in 0.1M phosphate buffer (PB; Merck, Germany).  Sections were then 
stained with cresyl violet stain (0.5% w/v, Sigma, USA) to identify the dye spot and 
stimulation sites.   
 
2.5.2 c-Fos immunohistochemistry 
 
In experiments where hippocampal c-Fos expression was examined (see section 2.4.4 
Investigation of the effect of intra-SuM carbachol microinjection on hippocampal c-
Fos expression), the animal was transcardially perfused with 1% w/v sodium nitrite 
(Merck, Germany) made in 0.5M PB (Merck, Germany) followed by 4% w/v 
paraformaldehyde (Merck, Germany) made in 0.1M PB (Merck, Germany).  The 
brain was removed and immersed in the fixative for 24hrs at 4
o
C.  60µm coronal 
sections were made on a vibrotome (LeicaVT1200, Leica, USA) and collected in 
0.05M Tris buffered saline (TBS; Sigma, USA).  To visualize c-Fos expression, 
immunohistochemistry was carried on the coronal sections as previously described 
(Khanna et al., 2004).  Sections from the anterior (P2.30-2.80mm), middle (P3.14-
3.80mm) and posterior (P4.80-5.30mm) hippocampus (Paxinos and Watson, 1997), 
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were immunolabled for c-Fos protein expression, using the avidin-biotin-peroxidase 
method of visualization. The protocol was carried out at room temperature unless 
otherwise stated.  Sections were placed in a 24-well plate (one brain section per well) 
with 300µl of each solutions per well.  The primary and secondary antibodies were 
diluted with 3% w/v bovine serum albumin (BSA, Sigma, USA).  An orbital shaker 
(Stuart Scientific, UK) at 50 revolutions per minute was used during washes and 
incubations.  The protocol used is described below in sequential order:  
 
1. Incubation with 0.3% v/v stabilised hydrogen peroxide (Merck, Germany) for 
20mins to remove endogenous catalase activity.  Subsequently, sections were rinsed 
twice with TBS (Sigma, USA) for 15mins each.   
2. Blocking of sections in 3% w/v BSA (Sigma, USA) in 0.05M TBS (Sigma, 
USA) with 0.3% v/v Triton X-100 (Merck, Germany) for 2 hours.   
3. Without rinsing, sections were incubated in anti-c-Fos primary antibody 
(1:2000 rabbit anti-Fos polyclonal antibody; Ab-5, Oncogene, USA) for 72 hours at 
4
o
C.   
4. Sections rinsed with TBS for 15mins.   
5. Incubation in anti-rabbit secondary antibody (1:1000 biotinylated goat anti-
rabbit polyclonal antibody, Calbiochem, USA) overnight at 4
o
C.   
6. Sections rinsed with TBS for 15mins.   
7. Incubation with ABC solution (Vectastain ABC Kit, Vector Laboratories, 
USA) for 3hrs.  The ABC solution consists of the avidin and biotinylated horse radish 
peroxidase (HRP) complex.  This complex would conjugate with the tissue bound 
biotinylated secondary antibody.   
8. Sections rinsed with TBS for 15mins.   
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9. Incubation with 0.025% w/v diaminobenzidine (DAB; Sigma, USA) in 0.05M 
TBS (Merck, Germany) for 10mins without shaking.   
10. Development of brown precipitation with a solution of 0.025% DAB in 0.05M 
TBS solution in the presence of 0.1% v/v hydrogen peroxide.  HRP reacts with DAB, 
catalysed by hydrogen peroxide, to form a brown precipitate.  Once the brown 
immunolabel has achieved the desired intensity, the reaction was quenched by 
immersing the sections in 0.05M TBS.   
11. Sections mounted on 0.5% w/v gelatin (Sigma, USA) coated slides and air 
dried.   
12. The air-dried sections were further dehydrated using ethanol (100% v/v; 
Merck, Germany), ethanol-xylene (50% v/v; Merck, Germany) and xylene (100% v/v; 
Merck, Germany) solutions sequentially before cover slipped with the mounting 
medium DePeX (Merck, Germany).   
 
2.5.3 Double immunofluorescent histochemistry 
 
In some experiments, using double immunofluorescence staining methods, 
investigations were carried out to identify the biochemical nature of the c-Fos positive 
hippocampal neurons.  Sections were double stained for c-Fos and either PV, SOM or 
nNOS protein expression.  The protocol used is described in sequential order below:  
 
1. Sections were incubated in blocking solution comprising of 3% w/v BSA 
(Sigma, USA) in 0.05M TBS (Sigma, USA) and 0.3% v/v Triton-X 100 (Merck, 




2. Subsequently, the sections were incubated in the primary antibody for 72hrs at 
4
o
C with the following antibodies:   
 
Antigen Host Source Dilution 
c-Fos Rabbit (polyclonal) Calbiochem, USA 1:2000 
PV Mouse (monoclonal) Sigma, USA 1:2000 
SOM Mouse (monoclonal) GeneTex, Inc., USA 1:25 
nNOS Mouse (monoclonal) Santa Cruz Biotchnology, USA 1:50 
 
The primary antibodies were diluted in 0.3% TX-TBS, comprising of 0.3% v/v Triton 
X-100 (Merck, Germany) in 0.05M TBS (Sigma, USA).  The primary antibodies for 
c-Fos and the paired antigen were incubated concurrently.   
3. Sections were then washed with 0.3% TX-TBS 3 times (5mins each time) 
without shaking.   
4. Following that, the sections were concurrently incubated with the same pair of 
fluorophore-labeled secondary antibodies (1:200 dilution in 0.3% TX-TBS, as in 2) in 
the dark at room temperature without shaking for 1hr as follow:   
Antigen Host Source Fluorophore 





Alexa Fluor 488 
Mouse anti-PV antibody Alexa Fluor 647 
Mouse anti-SOM antibody Alexa Fluor 647 
Mouse anti-nNOS 
antibody 
Alexa Fluor 647 
 
5. Sections were washed with 0.3% TX-TBS 3 times (5mins each time) without 
shaking.   
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6. Sections were then mounted on 0.5% w/v gelatin (Sigma, USA) coated slides 
and air dried.   
7. The air dried sections were coverslipped with Gelmount aqueous mounting 
medium (Sigma, USA).   
 
2.6 Data Analyses 
 
Electrophysiological data were digitized (PS at 10kHz and EEG at 256Hz) and 
collected using Spike2 software (Cambridge Electronic Design, UK).  The data were 
analyzed offline for the following measures: i) time course of change in PS amplitude 
(mV), ii) average percentage suppression (%), iii) latency to onset of theta (s), (iv) 
time course of duration of theta wave activity (s/min), (v) time course of fast Fourier 
transform (FFT) peak power in the theta range of 3-6 Hz (FFT theta peak power; 
mV
2
), iv) average FFT theta peak power (mV
2
), and v) the average FFT theta peak 
frequency (Hz). 
 
The amplitude of the PS was calculated as the average of the negative peak from the 2 
positive peaks around it (Fig 2.2; Jiang and Khanna, 2004; 2006).  The PS amplitude 
reflects the nearly synchronous discharge of a population of CA1 pyramidal cells and 
an increase in the amplitude of the spike reflects an increase in the number of cells 
firing.  For analyses of the time course of effect of various manipulations, the PS was 
averaged in 1min blocks (six sweeps per minute).  The average percentage 
suppression of the PS amplitude immediately following a manipulation was 
determined by calculating the reduction in the average amplitude of the PS in the 





























Fig 2.2 Trace of a CA1 population spike (PS) evoked by CA3 stimulation (single 
pulse, 0.01ms, 0.1Hz) of the ipsilateral hippocampus.  The arrow points to the 
stimulus artifact generated by CA3 stimulation.  The stimulus voltage was adjusted to 
evoke a population spike (PS) amplitude that is 70% of the maximum.  PS amplitude 
was calculated as the average of the negative peak (lower arrow head) to the adjacent 















































amplitude in the preceding 2min and expressed as percentage of control (control taken 
as 100%).  Duration of theta was determined by calculating the time period (in second 
per 1min block) for which hippocampal field activity displayed rhythmic slow wave 
activity at 3–6 cycles/sec in the EEG trace.  Latency to theta was defined by 
measuring the time (sec) of onset of sustained theta following carbachol/glutamate 
microinjection or sensory stimulation.  FFT analyses (frequency resolution of 0.5 Hz) 
of carbachol/glutamate- or sensory stimulation-induced field activity were performed 
only on theta waves taken from 10s block of EEG (band pass filtered at 1-10 Hz) 
between consecutive CA3 stimulation and averaged for six such blocks to give the 
value of theta peak power and theta peak frequency per 1min.  Similar FFT analyses 
were performed on 2sec segment of theta activity from the onset of reticular (RPO) 
stimulation.  The average FFT theta peak power was the average power in two 1min 
blocks.  In some cases, the FFT theta peak power was normalized to the average theta 
peak power during the 10min of RPO stimulation before microinjection of the drugs.  
The average theta power during this 10min period was taken to be 1.0.   
 
Hippocampal c-Fos expression was analysed from six sections, two each from the 
anterior, middle and posterior hippocampus (see section 2.5.2 – c-Fos 
immunohistochemistry).  c-Fos expression in the hippocampal fields CA1-3 
(including the stratum oriens, radiatum and lacunosum moleculare) and the DG 
(including the molecular layer and hilus) was manually counted using an Olympus 
microscope and identified as a brown spherical nucleus that was distinct from the 
background.  The intensity of c-Fos immunostaining of granular layer of the DG was 
analaysed using the AIS Image Analysis Software (Imaging Research Inc, Canada).  
The intensity of labeling in the granular layer of the DG (ipsilateral to the 
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microinjection site in the lateral SuM) was computed as a ratio to the granular layer of 
the contralateral DG.  c-Fos positive neuronal counts and intensity values were 
averaged across the six selected sections.   
 
Fluorescent images were captured using a Zeiss LSM510 confocal microscope (Carl 
Zeiss, Germany), equipped with an Argon laser line of 488nm and a Helium-Neon 
laser line of 543nm and 633nm respectively.  Alexa Fluor 488 was viewed with 505-
530nm band pass filters and Alexa Fluor 647 was viewed with a 650nm long pass 
filter.  The images were captured using a pinhole of 1.0 Airy unit with a 20X 
magnification objective.   
 
The data are expressed as mean + SEM.  Statistical comparisons of raw data are made 
using i) one way repeated measure ANOVA or one way ANOVA followed by 
Newman-Keul’s test for multiple comparison, ii) two-tail paired t-test, and iii) two-
tail unpaired T-test.  Significant differences between compared values were accepted 



































3.1 Pilot study to select the concentration of atropine 
 
This study was performed to determine a lower concentration of atropine that is 
effective in antagonizing the hippocampal effects of intra-SuM carbachol (0.1µl, 
0.85mM).  Three concentrations of the antagonist were tested, i.e. 0.005mM (n = 4), 
0.01mM (n = 4) and 0.05mM (n = 2).   
 
During the course of the experiment, carbachol was microinjected every 60 mins for 5 
times, whereas the antagonist (0.1l of atropine) was microinjected 5min before the 
3
rd
 carbachol administration.  The effects on hippocampal responses of the first two 
microinjections were comparable and therefore the data for the two were averaged 
and plotted as ‘Control’.  Whereas, the 3rd microinjection, which was preceded by 
microinjection of an antagonist, was plotted as Atro-C3 where Atro denote the 





 carbachol is given by the plots labeled C4 and C5, respectively.   
 
Carbachol microinjection evoked a strong and sustained ‘Control’ suppression of CA1 
PS amplitude (Fig 3.1, left; Time, F 23, 23 = 8.731 at least, P < 0.0001, n = 2 at least), 
whereas pre-treatment with 0.05mM or 0.01mM atropine strongly attenuated the 
carbachol-induced average %  suppression of the PS amplitude (Fig 3.1, right; 
0.05mM: Treatment, F 3, 7 = 26.61, P < 0.005, n = 2; 0.01mM: Treatment, F 3, 15 = 
8.325, P < 0.003, n = 4).  However, the carbachol-induced average % suppression was 
not affected by pre-treatment with 0.005mM of atropine (Fig 3.1, right; Treatment,  
F 3, 15 = 0.6609, P > 0.500, n = 4).  Similarly, the average theta power was attenuated 
with 0.05mM and 0.01mM atropine microinjection (Treatment, F 3, 19 = 3.713 at least,







Fig 3.1  The concentration-dependent effect of the muscarinic cholinergic receptor 
antagonist, atropine, on carbachol induced suppression of dorsal hippocampus field 
CA1 population spike (PS).  The drugs were microinjected via a double barrel cannula 
that was oriented along the rostrocaudal axis of the supramammillary nucleus (SuM).  
The control PS amplitude, recorded under conditions of large irregular activity in the 
EEG prior to microinjection of the agonist, was 70% of the maximal amplitude.  
Carbachol (0.1l, 0.85mM) was microinjected at time 0min (left panels).  The PS 
amplitude was calculated in blocks of 1min from at least 2min before (-2min and -
1min) and 20min after the agonist microinjection and also at selected time points 
thereafter (left panels).  The average percentage suppression of the PS amplitude was 
determined by calculating the reduction in the amplitude of the PS in the 2min period 
following drug treatment from the control amplitude in the preceding 2min and 
expressed as percentage of control (control taken as 100%; right panels).  During the 
course of the experiment, carbachol was microinjected every 60min for 5 times, 
whereas the antagonist (0.1l of atropine) was microinjected 5min before the 3rd 
carbachol administration.  The microinjection of carbachol alone evoked a robust 
suppression that was comparable between the first and the second microinjections.  
Therefore, the data for the two were averaged and plotted as ‘Control’.  Whereas, the 
response to the 3
rd
 microinjection is labeled as Atro-C3 where Atro denotes the 
antagonists (atropine) and C3 signifies the 3
rd





 carbachol is given by the plot labeled C4 and C5, respectively.  Three 
different concentrations of atropine (0.1µl) were tested namely 0.05mM (A), 0.01mM 
(B) and 0.005mM (C).  Notice that the carbachol-induced is strongly attenuated by 
0.05 and 0.01mM, but not 0.005mM atropine.  Each point on the line graph and each 
bar in the histogram represents mean + S.E.M.  For the purpose of clarity, significant 
difference at the individual time points is indicated only for the ‘Control’ plots in the 
left panels.  Significant difference (P < 0.05): * vs. PS amplitude at -2 and -1min in 













































































































































































































































P < 0.03, n = 4 at least; data not shown), but not by 0.005mM atropine (Treatment,  
F 3, 15 = 0.6609, P > 0.5, n = 4; data not shown).  As such, 0.01mM atropine was 
selected for subsequent experiments.   
 
3.2 Effect of cholinergic antagonists on carbachol- and glutamate-induced 
hippocampal activity 
 
This experiment examined the effect of intra-SuM microinjection of atropine or the 
cholinergic-nicotinic receptor antagonist, mecamylamine, on carbachol- or glutamate-
induced hippocampal neural responses.  Carbachol or glutamate microinjection 
(0.1l, 0.05mM) was applied as explained above.  Similarly, the antagonist (0.1l of 
either 10mM mecamylamine or 0.01mM atropine) was microinjected 5min before the 
3
rd
 carbachol (or glutamate) administration.  The nomenclature followed while 
describing the data is as explained above.  Thus, the data is described in terms of 
‘Control’ Atro-C3 (carbachol/atropine sub-group) and Mec-C3 




 carbachol is 
given by the plots labeled C4 and C5, respectively.  A similar nomenclature was 
followed with the SuM glutamate group, except that the term ‘G’, reflecting the use of 
glutamate, replaced the term ‘C’ that reflected the microinjection of carbachol.   
 
3.2.1 Microinjection sites 
 
The drugs were microinjected using a double barrel cannula such that the anterior 
cannula was filled with carbachol (or glutamate) solution while the posterior cannula 




the sites of carbachol (or glutamate) microinjection were anterior to that of the 
antagonist (Fig. 3.2).  The majority of the carbachol microinjection sites were in SuM 
or at the border of the SuM from where a short latency effect was observed on CA1 
(Fig. 3.2 A, B).  These experiments were all grouped together for analyses (SuM 
carbachol group).  The corresponding antagonist microinjection sites for these 
experiments were in the SuM region or caudal to it (Fig. 3.2A, B).  The glutamate and 
the corresponding antagonist microinjection sites were all in the SuM region (Fig. 
3.2C, D) and comprised an experimental group (SuM glutamate group).   
 
3.2.2 Effect of antagonists on carbachol and glutamate induced PS amplitude 
suppression  
 
The ‘Control’ effect of carbachol in the SuM carbachol group was marked by robust 
suppression of the CA1 population spike (Fig 3.3; Time, F 23, 230 = 24.71, P < 0.0001, 
n = 11 for carbachol/mecamylamine sub-group, Fig 3.3A; Time, F 23, 184 = 24.77, P < 
0.0001, n = 9 for carbachol/atropine sub-group, Fig 3.3B).  The strength of 
suppression ranged from 38%-96%.  A significant suppression was also seen at C3, 
C4 and C5 following mecamylamine (Fig. 3.3A; Time, F 23, 230 = 6.924 at least, P < 
0.0001, n = 11) and atropine pre-treatment (Fig. 3.3B; Time, F 23, 184 = 2.241 at least, 
P < 0.0001, n = 9), although the average percentage suppression was attenuated (Fig 
3.3, Table 1; Group, F 3, 40 = 13.41, P < 0.0001, n = 11 for the 
carbachol/mecamylamine group; Group, F 3,32 = 4.437, P < 0.0200, n = 9 for the 
carbachol/atropine group).  A strong effect of the two antagonists was observed 
irrespective of the strength of carbachol-suppression.  For example, in 8 experiments, 
the average ‘Control’ suppression was > 70%.  The average ‘Control’ suppression in  












Fig 3.2  Diagrammatic representation of the microinjection sites in the 
carbachol/mecamylamine (A), carbachol/atropine (B), glutamate/mecamylamine (C) 
and glutamate/atropine (D) sub-groups.  The figures below each diagram represent the 
coordinates posterior to the Bregma, based on Paxinos and Watson (1997).  The 
vertical line from the retroflexus fasciculus (not indicated) to the SuM divides the 
SuM into the medial SuM (mSuM) and lateral SuM (lSuM), in accordance with Jiang 
and Khanna (2006).  The drugs were microinjected via a double cannula setup.  The 
cannulas were fused and attached to an Exmire microsyringe via polythene tubing.  
The double cannula, with an external diameter of 100µm, was oriented along the 
rostrocaudal axis of the supramammillary nucleus (SuM).  The anterior cannula was 
filled with carbachol (    , 0.85mM) or glutamate (     , 0.05mM).  The posterior 
cannula was filled with mecamylamine (     , 10mM) or atropine (    , 0.01mM), made 
in Alcian blue dye (0.5% w/v).  In each experiment, 0.1µl of each drug was 
microinjected into the SuM, according to the protocol indicated in Fig 2.1.  The 
identification of the microinjection sites was by the visualization of the dye spot from 
the posterior cannula and the cannula tract of the anterior cannula, thus in each 
experiment, a pair of microinjection sites are indicated in the diagrams.  The 
microinjection sites for carbachol and glutamate were observed from the most anterior 
(4.16mm posterior to Bregma) to the most posterior (4.80mm posterior to Bregma).  
In all instances, carbachol and glutamate microinjections evoked suppression of CA3 
evoked CA1 population spike and theta activation.  For some experiments in the 
carbachol sub-group, mecamylamine or atropine were microinjected into the ventral 
tegmental area (VTA), a structure contiguous with the SuM.  The effect of the 
antagonists was observed even though microinjected into the VTA.  In these set of 






























































































































Fig 3.3  The effect of the cholinergic receptor antagonists (mecamylamine, Mec or 
atropine, Atro) on carbachol-induced suppression of dorsal hippocampus field CA1 
population spike (PS).  The drugs were microinjected (0.1µl) into the 
supramammillary nucleus (Fig 3.2).  The details of the protocol are as described in the 
legend to Fig 3.1 with the antagonist (10mM mecamylamine or 0.01mM atropine) 
microinjected 5min before the 3
rd
 carbachol administration.  Notice that both 
mecamylamine (A) and atropine (B) attenuated the carbachol-induced suppression of 
the CA1 PS amplitude.  Significant difference (P < 0.05): * vs -2min and -1min (left 
panel), vs ‘Control’ (right panel).  The asterisks in the left panels are illustrated for 
only the ‘Control’ response for clarity of illustration.   
 
 





























































































































Table 1  The effects of mecamylamine (Mec) and atropine (Atro) on carbachol-induced population spike (PS) suppression and theta activation in dorsal 




(one way ANOVA statistics) 
Carbachol 
Control C3 C4 C5 
      
Average percentage 
suppression of PS 
(%) 
Mec (n = 11) 
(F 3, 40 = 13.41, P < 0.0001) 
70.65 + 4.75 31.06 + 6.72* 27.76 + 4.44* 46.18 + 5.14* 
Atro (n = 9) 
(F 3, 32 = 4.437, P < 0.02) 
50.81 + 5.98 22.29 + 6.47* 25.43 + 5.27* 25.54 + 7.33* 
      




Mec (n = 12) 
(F 3, 44 = 5.339, P < 0.004) 
0.003354 + 0.000262 0.002313 + 0.000334* 0.001915 + 0.000189* 0.002424 + 0.000249* 
Atro (n = 12) 
(F 3, 44 = 5.504, P < 0.003) 
0.005470 + 0.000969 0.003146 + 0.000550* 0.001951 + 0.000291* 0.002691 + 0.000593* 
      
Average theta 
duration (sec/min) 
Mec (n = 12) 
(F 3, 44 = 7.102, P < 0.0006) 
43.38 + 0.40 27.88 + 3.53* 31.46 + 3.06* 35.63 + 1.74* 
Atro (n = 12) 
(F 3, 44 = 6.329, P < 0.002) 
42.00 + 1.43 27.42 + 4.14* 24.63 + 3.43* 26.42 + 3.02* 
      
Average theta 
frequency (Hz) 
Mec (n = 12) 
(F 3, 44 = 0.4836, P > 0.6) 
4.904 + 0.11 4.760 + 0.13 4.718 + 0.11 4.760 + 0.12 
Atro (n = 12) 
(F 3, 44 = 1.775, P > 0.1) 
4.413 + 0.16 3.944 + 0.21 3.861 + 0.18 4.027 + 0.18 
      
Latency to theta (sec) 
Mec (n = 12) 
(F 3, 44 = 7.637, P < 0.0004) 
8.708 + 0.53 46.75 + 8.23* 39.67 + 7.16* 28.42 + 5.00* 
Atro (n = 12) 
(F 3, 44 = 18.18, P < 0.0001) 
8.583 + 0.93 66.25 + 9.42* 64.17 + 6.78* 69.83 + 7.19* 
 
An average value was the average of the response in the 2 min period following microinjection of carbachol into the supramammillary nucleus (SuM) before 
(Control) or after (C3-C5) microinjection of either Mec or Atro into SuM.  The experimental protocol was as explained in Fig. 2.1.  Latency to theta was the time 
from microinjection of carbachol to the onset of sustained hippocampal theta wave activity.  The values are mean + SEM.  The ANOVA statistics reflect the ‘Group’ 
comparison involving the data from the control, and the C3-C5 groups.  Significant difference (P < 0.05): * vs. corresponding control.   
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this group was 80.48 + 3.70% (n = 8), which was significantly attenuated (Groups, F 
3, 31 = 12.45, P < 0.0001, n = 8) to 28.30 + 8.86%, 27.28 + 5.66% and 42.06 + 8.68% 
(n = 8; carbachol/mecamylamine sub-group, n = 5; carbachol/atropine sub-group, n = 
3) at C3, C4 and C5, respectively.   
 
The glutamate-induced suppression was unaffected by the antagonists and the 
suppression seen at G3, G4 and G5 in the glutamate/mecamylamine sub-group and 
glutamate/atropine sub-group was comparable to the corresponding ‘Control’ 
responses (Figs. 3.4, 3.5, Table 2; Time, F 23, 69 = 13.98 at least, P < 0.0001, n = 4 for 
the glutamate/ mecamylamine group; Time, F 23, 69 = 11.73 at least, P < 0.0001, n = 4; 
for the glutamate/ atropine group; also see Table 2).  The strength of glutamate-
induced average ‘Control’ suppression was greater (83.09 + 4.06%, two tail unpaired 
t-test, P < 0.008) than that observed with carbachol microinjection in the wider 
carbachol group (61.72 + 4.294%, n = 20), but comparable to that seen in the sub-set 
of the carbachol group with average ‘Control’ suppression of > 70% (two tail 
unpaired t-test, P > 0.6).  The basal PS amplitudes were not different between the 
glutamate vs. carbachol groups (two tail unpaired t-test, P > 0.1).   
 
3.2.3 Effect of antagonists on carbachol and glutamate-induced theta activation 
 
Pre-treatment with the two antagonist attenuated carbachol-, but not glutamate-evoked 
hippocampal theta activation (Fig 3.6, Tables 1, 2).  The average ‘Control’ power of 
carbachol-induced theta (0.004412 + 0.000538 mV
2
; n = 24) was similar (two tail 
unpaired t-test, P > 0.1) to the corresponding value with glutamate microinjection 
(0.003026+ 0.000247 mV
2
; n = 8).  The effect of the antagonists on the carbachol- 






































Fig 3.4  The lack of effect of the cholinergic receptor antagonists (mecamylamine, 
Mec or atropine, Atro) on glutamate (0.1l, 0.05mM)-induced suppression of dorsal 
hippocampus field CA1 population spike (PS).  The figure is developed as explained 
in Figs. 3.1 and 3.3 except that the term ‘G’, reflecting the use of glutamate, replaced 
the term ‘C’ that reflected the microinjection of carbachol.  Notice the two antagonists 
did not influence the suppression induced by glutamate microinjection.  Significant 
difference (P < 0.05): * vs. -2 and -1min.  The asterisks in the left panels are 




























































































































































Fig 3.5  Mecamylamine (10mM) selectively antagonizes carbachol (0.85mM)-
induced suppression of CA1 population spike (PS; A) while sparing glutamate 
(0.05mM)-induced suppression (B).  The drugs were microinjected (0.1l) into the 
supramammillary nucleus.  The details of the protocol are as described in the legend 
to Fig. 3.1.  The PS traces represent the average PS in 1-min block before (-1min) and 
after (1min to 20min) carbachol (or glutamate) microinjection, without (representing 
the 2
nd
 microinjection - dark traces) or with mecamylamine (representing the 3
rd
 
microinjection - red traces) pretreatment.  The two set of traces in A and B are shown 
superimposed by aligning them at the onset of the stimulus.  Note that both carbachol 
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Fig 3.6  Mecamylamine (Mec) and atropine (Atro) attenuate carbachol-induced 
hippocampal CA1 theta power.  The figure is built as explained in Fig. 3.1.  The theta 
segments following carbachol microinjection were analyzed using the fast Fourier 
Transform (FFT).  Each time-point on the line graph reflects the average of six 
sweeps of theta segments in 1 min period with each sweep preceding CA3 stimulation 
that was spaced 10sec apart.  The histogram reflects the average theta power in 2mins 
following carbachol microinjection.  Each point on the line graph and bar in the 
histogram represents mean + S.E.M.  Significant difference (P < 0.05): * vs. ‘Control’ 










































































































Table 2  The lack of effect of mecamylamine (Mec) and atropine (Atro) on glutamate-induced population spike (PS) suppression and theta activation in the 




(one way ANOVA statistics) 
Glutamate 
Control G3 G4 G5 
      
Average percentage 
suppression of PS 
(%) 
Mec (n = 4) 
(F 3, 12 = 0.10, P > 0.4) 
89.39 + 4.13 87.15 + 5.31 82.83 + 3.52 80.78 + 2.11 
Atro (n = 4) 
(F 3, 12 = 0.21, P > 0.8) 
76.80 + 5.78 66.80 + 10.7 68.48 + 10.90 67.31 + 11.95 
      




Mec (n = 4) 
(F 3, 12 = 0.53, P > 0.6) 
0.00279 + 0.00029 0.00260 + 0.00034 0.00247 + 0.00012 0.00240 + 0.00010 
Atro (n = 4) 
(F 3, 12 = 0.87, P > 0.4) 
0.00326 + 0.00041 0.00386 + 0.00053 0.00415 + 0.00043 0.00345 + 0.00033 
      
Average theta duration 
(sec/min) 
Mec (n = 4) 
(F 3, 12 = 0.03, P > 0.9) 
36.56 + 0.66 36.50 + 1.93 37.00 + 0.89 36.63 + 1.52 
Atro (n = 4) 
(F 3, 12 = 0.29, P > 0.8) 
39.63 + 1.26 40.63 + 1.57 40.50 + 0.79 41.38 + 1.52 
      
Average theta frequency 
(Hz) 
Mec (n = 4) 
(F 3, 12 = 0.48, P > 0.7) 
4.45 + 0.16 4.26 + 0.25 4.38 + 0.13 4.13 + 0.24 
Atro (n = 4) 
(F 3, 12 = 1.66, P > 0.2) 
3.94 + 0.06 3.63 + 0.32 3.51 + 0.00 3.51 + 0.00 
      
Latency to theta 
(sec) 
Mec (n = 4) 
(F 3, 12 = 0.03, P > 0.9) 
25.13 + 1.33 25.00 + 3.85 26.00 + 1.78 25.25 + 3.04 
Atro (n = 4) 
(F 3, 12 = 0.03, P > 0.9) 
26.13 + 2.04 26.75 + 3.15 27.00 + 1.58 26.00 + 4.38 
      
 
The table is built as explained for Table 1.  The drugs were microinjected into the supramammillary nucleus.  The antagonists did not influence the 
response to glutamic acid microinjection.  The values are mean + SEM.   
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antagonism of carbachol-induced effects was observed on all the theta parameters, 
except on the FFT theta peak frequency that was unaffected (Table 1), whereas the 
antagonists did not affect glutamate-elicited changes (Table 2).   
 
3.2.4 Effect of antagonists on basal hippocampal responses 
 
The antagonists were also selective in so far that basal PS amplitude after the 
microinjection of the antagonists (but before carbachol or glutamate microinjection) 
were similar to that before the antagonist microinjections and also not different from 
the average PS amplitude in the 2min before each microinjection of carbachol or 
glutamate.  Similarly, paired-pulse suppression were not affected by the antagonists 
(P > 0.5, n = 9).   
 
3.2.5 Intra-VTA carbachol induced PS amplitude suppression and hippocampal 
theta activation  
 
In some instances, carbachol and the antagonists were microinjected into the anterior 
VTA (n = 9; n = 2 for the carbachol/mecamylamine group, n = 7 for the 
carbachol/atropine group) that is just caudal to the SuM (Fig 3.7).  ‘Control’ 
microinjection of carbachol into the anterior VTA elicited hippocampal theta 
activation at a longer latency compared to that seen with microinjections of the 
agonist into the SuM (SuM: 8.65 + 0.52sec, n = 24 vs. VTA: 40.06 + 8.93sec, n = 9; 
two-tail unpaired t-test, P < 0.0001).  Furthermore, the percentage suppression 
induced by intra-VTA carbachol was significantly lower compared to intra-SuM 
administration (SuM: 61.72 + 4.29%, n = 20 vs. VTA: 31.21 + 3.02%, n = 7; two-tail 
unpaired t-test, P < 0.0005).   
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Fig 3.7  Diagrammatic representation of the microinjection sites in the ventral 
tegmental area (VTA).  The coronal sections are adopted from Paxinos and Watson 
(1997) with the corresponding coordinates indicated on the left underneath each 

















No difference was seen in the effect of mecamylamine or atropine on intra-VTA 
carbachol-induced hippocampal responses and as such the groups were combined for 
analyses.  Microinjection of the antagonists had no effect on percentage PS amplitude 
suppression (Group, F 3, 27 = 0.714, P > 0.5, n = 7) or on average theta power (Group, 
F 3, 25 = 0.318, P > 0.8, n = 9).  However, the effect on the average theta  
duration and latency to theta was delayed and a statistically significant was observed 
with C5 microinjection.  Results of the experiments are summarized in Table 3.   
 
3.3 Effect of cholinergic antagonists on reticularly-elicited hippocampal 
activity 
 
In these experiments, discrete volume (0.1µl) of mecamylamine (10mM) or atropine 
(0.01mM) solution (with Alcian blue dye) was microinjected 10mins after the onset of 
reticular stimulation.  Drug was microinjected using a single 33G stainless steel 
needle coupled to an Exmire microsyringe.  The microinjection site was identified by 
the dye spot and included medial SuM and the lateral SuM (Fig. 3.8). 
 
3.3.1 Effect of reticular stimulation on PS amplitude and theta activation 
The strength of reticular (RPO) stimulation (T volts) was adjusted to evoke theta 
wave activity at about 4-5Hz frequency.  As previously (Jiang and Khanna, 2004), 
such stimulation evoked robust suppression of the CA1 PS.  The control amplitude of 
the CA1 PS in the two min prior to RPO stimulation was 6.27 + 0.11 mV (n = 22) and 
reflects the average across all experiments included in this section.  The average 
amplitude in the two min following onset of RPO stimulation was 2.20 + 0.20 mV (n 
= 22) and was significantly less from the control (P < 0.0001, two tail paired t-test).  






Table 3  The lack of effect of antagonists mecamylamine and atropine on intra-ventral tegmental area (VTA) carbachol-induced population spike 
(PS) suppression and theta activation in the dorsal hippocampus field CA1 
 
Parameter 
one way ANOVA 
statistics 
Carbachol 
Control C3 C4 C5 
      
Average percentage 
suppression of PS 
(%) 
F 3, 27 = 0.642, P > 0.50 31.21 + 3.02 20.76 + 7.58 23.94 + 6.00 29.70 + 6.80 
      




F 3, 35 = 0.318, P > 0.80 0.002626 + 0.000447 0.00238 + 0.000450 0.002058 + 0.000365 0.002277 + 0.000404 
      
Average theta 
duration (sec/min) 
F 3, 35 = 4.251, P < 0.02 28.25 + 3.967 24.61 + 4.305 12.56 + 5.26 8.56 + 4.66 * 
      
Average theta 
frequency (Hz) 
F 3, 35 = 0.162, P > 0.90 3.85 + 0.253 4.03 + 0.275 3.84 + 0.23 3.81 + 0.24 
      
Latency to theta 
(sec) 
F 3, 35 = 9.94, P < 0.0001 20.44 + 3.64 25.00 + 5.21 47.78 + 13.64 82.33 + 9.78 * 
      
 
The table is built as explained for Table 1.  The drugs were microinjected into the anterior VTA.  The values are mean + SEM.   
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Fig 3.8 Diagrammatic representation of cholinergic receptor antagonists 
(mecamylamine or atropine) microinjection sites in the supramammillary nucleus 
(SuM; lSuM being lateral SuM, while mSuM is medial SuM).  The antagonists were 
microinjected (0.1µl) using a single 33G needle so as to examine the effect of the drug 
microinjection on reticularly-elicited hippocampal responses.  The figure is built as 
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evoked average theta peak power and the average theta peak frequency were 
0.004571 + 0.000579 mV
2
 (n = 25) and 5.25 + 0.12 Hz (n = 25), respectively.   
 
3.3.2 Site and drug dependent effect of antagonist on RPO stimulation-induced 
hippocampal responses 
 
Drug microinjection evoked a drug and site-dependent effect on suppression and theta 
peak power.  Mecamylamine microinjection into ipsilateral lateral SuM (the left 
lateral SuM which is the same side as RPO stimulation) was most effective in 
attenuating both the suppression (Figs. 3.9 to 3.11; Time, F 23, 115 = 2.717, P < 0.0002; 
n = 6 for Fig 3.10) and the theta peak power (Figs. 3.9 to 3.11; Time, F 23, 138 = 6.973, 
P < 0.0001; n = 7 for Fig 3.10).  The effect was observed in the first minute, was long-
lasting and observed till the end of recording at 60
th
 min from the time of 
microinjection.  On the other hand, with microinjection of the antagonist into medial 
SuM, although an overall significant effect of the treatment was observed on the PS 
suppression (Time, F 23, 92 = 4.638, P < 0.0001; n = 5) and the theta peak power 
(Time, F 23, 115 = 2.382, P < 0.002; n = 6), the individual time points were not different 
from the control values at -2min and -1min (Figs. 3.9, 3.10A, B).  Likewise, atropine 
strongly antagonized the theta peak power when microinjected into ipsilateral lateral 
SuM.  The antagonism, seen within the first min of microinjection, was prolonged and 
observed till the end of recording at 60
th
 min after microinjection (Fig. 3.10B; Time, F 




 min post 
microinjection) effect was observed on the PS suppression after atropine 
microinjection into ipsilateral lateral SuM (Fig. 3.10A; Time, F 23, 161 = 2.716, P < 
0.0001, n = 8).  However, medial SuM atropine did not influence the RPO elicited PS 
suppression (Fig 3.10A; Time, F 23, 46 = 0.9774, P > 0.5, n = 3) and evoked a very 
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delayed (>20 min later) decrease in theta peak power (Fig. 3.10B; Time, F 23, 46 = 
3.79, P < 0.0001; n = 3).  In all cases, peak theta frequency was not affected by 
mecamylamine (Fig 3.10C; Time, F 23, 243 = 1.058 at least, P < 0.5, n = 6 at least) or 
atropine (Fig 3.10C; Time, F 23, 215 = 0.9037 at least, P < 0.6, n = 3 at least) in the 
mSuM or the ipsilateral lSuM.   
 
3.3.3 Effect of antagonists on subthreshold reticular stimulation 
 
It is notable that stimulation at T volt evokes maximal suppression (Jiang and Khanna, 
2004).  This, therefore, raises the possibility that the strong stimulation at T volt 
masked the effect of atropine on PS suppression.  To test this possibility, in some 
experiments we compared the PS suppression at T-1 volts before and at 60
th
 min after 
atropine microinjection.  A sub-maximal suppression is seen at T-1 volt although the 
stimulation intensity is sub-threshold for theta activation (Jiang and Khanna, 2004).  
Nonetheless, lateral or medial SuM atropine did not influence the PS suppression seen 
at T-1 volts (Fig 3.11).  The suppressed PS amplitude at T-1 volt before and 60min 
after atropine microinjection in the lateral SuM was 3.90 + 0.29 mV and 3.91 + 
0.27mV respectively (two-tailed paired t-test, P > 0.9, n = 8).  Similarly, medial SuM 
atropine microinjection had no effect on PS amplitude suppression at T-1 volt (Pre: 
3.53 + 0.49mV vs Post: 4.05 + 0.27mV; two-tailed paired t-test, P > 0.3, n = 3).  In 
comparison, microinjection of mecamylamine into the lateral SuM attenuated reticular 
stimulation evoked PS amplitude suppression at T-1 volt, with PS amplitude 
recovering significantly after microinjection of mecamylamine (Pre: 2.73 + 0.28mV 
vs Post: 4.75 + 0.56mV, two-tailed paired t-test, P < 0.02, n = 6).  No effect was 
observed with medial SuM mecamylamine treatment (Pre: 4.30 + 0.29mV vs Post: 
















Fig 3.9 Effect of mecamylamine (0.1µl, 10mM), microinjected into the 
supramammillary nucleus (SuM), on reticularis pontis oralis (RPO) stimulation-
induced suppression of the CA1 population spikes (PS; left column) and the power of 
theta wave activity (middle and right columns).  RPO was stimulated every 10s for 
2.56s at 100 Hz frequency with intensity that evoked about ~4-5 Hz theta wave 
activity.  The CA1 PS was evoked by stimulating hippocampal field CA3 at delay of 
10ms from the end of RPO stimulation.  Prior to the onset of RPO stimulation the 
amplitude of CA1 PS was adjusted at about 70% of maximal during irregular field 
activity (not illustrated).  Mecamylamine was microinjected 10min after the onset of 
RPO stimulation.  The time of mecamylamine microinjection is given by the 
horizontal arrow on left and was taken as 0min.  The antagonist was microinjected 
into the ipsilateral lateral SuM (lSuM; A) or the medial SuM (mSuM; B).  The PS 
traces represent the average PS in 1min block before (-1min) and after (1min to 
20min) microinjection of mecamylamine.  In the right column are the fast Fourier 
transforms (FFTs; frequency resolution of 0.5Hz) of the theta wave activity elicited 
on RPO stimulation.  The FFT theta peak power, expressed as log transform, is 
indicated beside the FFT.  The line from the FFT peaks to the scale underneath 
indicates the FFT frequency at the peak FFT power.  RPO stimulation evoked theta 
wave activity at the given power and a robust suppression of CA1 PS amplitude both 
of which were attenuated on microinjection of mecamylamine into the ipsilateral 
lSuM; whereas, microinjection of mecamylamine into the mSuM no effect.  Because 
the power expressed as log units was negative, a decrease in the normalised log power 
is reflected by shift to higher numerical values.  Theta frequency was not affected by 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig 3.10  The time course of effect of the cholinergic receptor antagonists on RPO-
elicited population spike (PS) suppression (A), theta power (B) and theta frequency 
(C).  Discrete volume (0.1l) of mecamylamine (10mM) or atropine (0.01mM) 
solution was microinjected into the ipsilateral lateral supramammillary nucleus 
(lSuM) or the medial SuM (mSuM).  The reticular formation was stimulated as 
explained in the Figure 3.9.  The antagonist was microinjected at time 0min which 
was 10min after the onset of RPO stimulation (starting from -10min on the plot).  The 
control amplitude of CA1 PS shown at -12min and -11min was adjusted at about 70% 
of maximal during irregular field activity (on left in A).  RPO stimulation evoked 
theta wave activity and a robust suppression of CA1 PS amplitude.  Both the PS 
amplitude and theta power were calculated in blocks of 1min.  Theta power was 
normalised to the average theta power in the 10min before drug microinjection.  
Microinjection of mecamylamine into the ipsilateral lateral, but not medial SuM 
attenuated both the PS suppression and the power of theta wave activity at relatively 
short latency.  Atropine microinjection into ipsilateral lSuM also attenuated theta 
power and evoked a much delayed effect on PS suppression.  Similarly, the 
attenuation of theta power by atropine in the mSuM (right panel in B) was much 
delayed.  However, atropine did not affect PS suppression when microinjected into 
the medial SuM.  Theta frequency was unaffected by microinjection of 
mecamylamine or atropine.  Significant difference (P < 0.05): * vs. corresponding 
values at -2min and -1min.  The statistical significance was calculated using one-way, 
repeated-measure ANOVA followed by Newman–Keuls test for multiple 
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Fig 3.11  Effect of mecmaylamine (Mec, 0.1µl, 10mM) and atropine (Atro, 0.1µl, 
0.01mM) on RPO stimulation intensity dependent suppression of CA1 population 
spike (PS) amplitude.  The antagonists were microinjected into the medial SuM 
(mSuM) or the lateral SuM (lSuM).  Reticular stimulation at T-1 volts suppressed 
CA1 PS amplitude without inducing theta wave activity.  Increasing the RPO 
stimulation intensity to T or T+1 volts enhanced the suppression and in addition, 
elicited theta wave activity (not illustrated).  ‘Control’ PS amplitude was recorded 
during LIA EEG.  PS amplitude suppression was selectively affected by Mec but not 
Atro at all stimulation intensities.  Significant different (P < 0.05): * vs ‘before’ 
values at the same stimulus intensity.   
 





























































































3.4 Effect of cholinergic antagonist on sensory stimulation–induced 
hippocampal activity 
 
Sensory stimulation consisted of subcutaneous injection of formalin (5%, 0.05ml) into 
the hind paw.  Such injection recruits nociceptors and evokes a prolonged theta 
activation and suppression of CA1 PS in anaesthetized rat (Khanna, 1997).  Formalin 
was injected into the right and the left hind paw, at least 3 hour apart, in a counter 
balanced fashion.  The microinjections were into the left lateral SuM region (Fig. 
3.12) and were performed 5min after hind paw injection of formalin.  The cholinergic 
antagonist was microinjected into the lateral SuM since the preceding experiments 
suggested that the microinjection of these drugs into this region modulated the 
ascending reticular relay to the hippocampus.   
 
As previously (Khanna, 1997), hind paw injection of formalin evoked a robust 
suppression of CA1 PS in parallel with theta activation.  The control amplitude of the 
CA1 PS in the two min prior to formalin injection was 6.09 + 0.10 mV (n = 17; the 
‘n’ value reflects experiments with mecamylamine and atropine and includes the 
amplitudes before the ipsilateral and the contralateral formalin injections).  The 
average amplitude in the two min following formalin injection was 2.58 + 0.17 mV (n 
= 17) and was significantly less from the control (P < 0.0001, two tail paired t-test).  
The average percent suppression was 57.69 + 2.73%.  The accompanying average 
theta peak power and the average theta peak frequency were 0.003229 + 0.00025 mV
2
 
(n = 17) and 4.01 + 0.07 Hz (n = 17), respectively.  Both the suppression and the theta 

























 Fig 3.12  Diagrammatic representation of intra-lateral SuM microinjection sites of 
mecamylamine and atropine.  The figure is built as in Fig 3.2.  Mecamylamine (0.1µl, 
10mM) or atropine (0.1µl, 0.01mM) was microinjected so as to examine the effect of 
the antagonist on hippocampal responses elicited by hind paw injection of the 
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Interestingly, of the two cholinergic antagonists tested, only mecamylamine was 
effective in antagonizing the effect of formalin injection, and the antagonism was 
lateralized.  Thus, mecamylamine microinjected into left lateral SuM antagonized the 
PS suppression (Fig 3.13; Time, F 23, 92 = 4.240, P < 0.0001, n = 5) and theta peak 
power (Fig. 3.13; Time, F 23, 92 = 4.911, P < 0.0001, n = 5) elicited by injection of 
formalin into the right (contralateral) hind paw.  The latency to 20% change in PS 
suppression and theta power was 22.00 + 4.89s (n = 5) and 20.00 + 3.16s (n = 5), 
respectively.  On the other hand, lateral SuM microinjection of mecamylamine did not 
affect PS suppression (Fig. 3.13; Time, F 23, 92 = 1.012, P > 0.4, n = 5) induced on 
injection of formalin into the left (ipsilateral) hind paw.  An overall significant effect 
of the treatment was observed on the left-hind-paw-formalin-induced theta peak 
power (Fig. 3.13; Time, F 23, 69 = 1.911, P < 0.03, n = 4).  However, the effect of 
mecamylamine was not marked and none of the time points after the drug 
microinjection were different from control values at -2min and -1min prior to the 
microinjection.  Unlike mecamylamine, the muscarinic antagonist, atropine, was 
without an effect on responses elicited by injection of formalin in the ipsilateral or the 
contralateral hind paw.  The ANOVA statistics for atropine are as follows: a) PS 
suppression- Time, F 23, 69 = 0.7257, P > 0.8, n = 4 for contralateral hind paw formalin 
injection and Time, F 23, 46 = 1.535, P > 0.1, n = 3 for ipsilateral hind paw formalin 
injection, and b) theta peak power- Time, F 21, 84 = 1.497, P > 0.1, n = 5 for 
contralateral hind paw formalin injection and Time, F 23, 46 = 0.9758, P > 0.5, n = 3 for 
ipsilateral hind paw formalin injection (Fig. 3.13).  The average percentage 
suppression and the average theta peak power with right (contralateral) hind paw 
injection of formalin in the 2min before vs. 2min after mecamylamine was 67.06 + 
4.11% (n = 5) and 0.003361 + 0.0004806 mV
2
 (n = 5) vs. 41.65 + 1.72% (n = 5) and 
0.002257 + 0.000423 mV
2
 (n = 5).  The values after mecamylamine were significantly  
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Fig 3.13  The time course of effect of mecamylamine (A; 0.1µl, 10mM) and atropine 
(B; 0.1µl, 0.01mM) on formalin-induced suppression of CA1 population spike (PS) 
and th generation of theta power.  Formalin (0.05ml, 5% s.c.) was injected into the 
two hind paws 3hrs apart in a counter-balanced fashion.  The PS amplitude 
preceeding each formalin injection was about 70% of maximal amplitude under 
irregular hippocampal field activity.  The time of formalin injection taken at -5min 
while the drug was microinjected 5min later at time 0min.  Theta power was 
normalized to the average theta power in the 5min period between formalin injection 
and microinjection of the antagonists.  Mecamylamine attenuated PS amplitude 
suppression (A, left) and theta power (A, right) induced by formalin injected into the 
contralateral but not the ipsilateral paw.  Atropine was ineffective in attenuating PS 
amplitude suppression (B, left) and theta power (B, right) with formalin injected into 
either paw.  Significant difference (P < 0.05): * vs -2 and -1min 
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less compared to the corresponding values before mecamylamine (Fig 3.14, two tail 
paired t-test, P < 0.04 at least).  The average percentage PS amplitude suppression and 
the theta peak power with left (ipsilateral) hind paw injection of formalin in the 2min 
before vs. 2min after mecamylamine was 51.66 + 3.68% (n = 5) and 0.003670 + 
0.000518 mV
2
 (n = 4), vs. 51.79 + 4.44% (n = 6) and 0.003306 + 0.000483 mV
2
 (n = 
4).  The corresponding values, before and after mecamylamine, was not different from 
each other (Fig 3.14, two tail paired t-test, P > 0.5).  The control average theta 
duration (average of two minute before drug microinjection) induced by injection of 
formalin into the contralateral hind paw before the microinjection of the antagonists 
into the lateral SuM was 47.20 + 0.80s (n = 5) and 48.00 + 0.0s (n = 5) for the 
mecamylamine and the atropine groups, respectively.  Following the microinjection of 
the antagonists, the corresponding average theta duration (average of two minutes 
after drug microinjection) was 29.30 + 3.50s and 44.20 + 2.11s.  Only the duration of 
theta wave activity following injection of formalin in the contralateral paw was 
attenuated by mecamylamine microinjection into the lateral SuM (Fig 3.14, two tail 
paired t-test, P < 0.02).  Atropine had no effect on theta duration (Fig 3.14, two tail 
paired t-test, P > 0.1).  When formalin was injected in the ipsilateral paw, 
mecamylamine (n = 4) and atropine (n = 3) had no effect on theta duration as 
compared to the corresponding control values prior to drug microinjection (Fig 3.14, 



















































Fig 3.14  Effect of mecamylamine (Mec, 0.1µl, 10mM) and atropine (Atro, 0.1µl, 
0.01mM) on formalin-induced suppression of PS amplitude and generation of theta 
wave activity.  The average percentage suppression, theta power and theta duration 
were analysed in the 2min period before and after the microinjection of Mec or Atro 
into the lateral SuM.  Mec attenuated hippocamal responses only with formalin 
injected into the contralateral hind paw but not the ipsilateral hind paw.  Atro had no 
effect on hippocampal induced responses when formalin was injected into either the 
ipsilateral or contralateral hind paw.  Significant difference (P < 0.05): * vs before 
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3.5 Effect of intra-SuM microinjection on hippocampal c-Fos expression 
 
To further explore the functional lateralization of the SuM, the expression of c-Fos 
protein, a marker of synaptic activation, was used to study the spatial pattern of 
hippocampal neural recruitment following carbachol stimulation of the SuM.  In this  
context, carbachol (0.1µl) was microinjected into the medial or lateral SuM, following 
which, c-Fos immunohistochemistry was carried out on selected hippocampal 
sections.   
 
3.5.1 A qualitative description of differential hippocampal activation by medial vs. 
lateral SuM carbachol microinjection 
 
Microinjection of carbachol into the left lSuM induced a distinctive pattern of c-Fos 
expression in the hippocampus, whereby the ipsilateral (left) hippocampus was 
intensely stained but not the contralateral (right) hippocampus (Fig 3.15).  Positive 
immunolabeling was observed in all layers of the ipsilateral hippocampus.  
Interestingly, staining of the ipsilateral DG was observed as a dense dark band (Fig 
3.16).  In contrast, microinjection of carbachol into the mSuM evoked a different c-
Fos expression pattern.  There was no visible difference between the ipsilateral and 
contralateral hippocampus.  The intense staining of the DG was also obviously absent 
in mSuM.   
 
3.5.2 A qualitative evaluation of hippocampal recruitment by carbachol in lSuM 
 
Quantification of c-Fos expression was through a manual count except for the DG, 











































Fig 3.15  Low magnification (4X) photomicrographs (600dpi) showing ipsilateral c-
Fos protein expression following microinjection of carbachol into the left lateral SuM.  
The left (L) hippocampal dentate gyrus (DG), ipsilateral to the microinjection site, 
was intensely stained and observed as a dark band.  In contrast, the right (R) DG 




















Fig 3.16  High magnification (40X) micrographs (600dpi) depicting ipsilateral c-Fos 
expression in the hippocampus following carbachol microinjection in the left lateral 
SuM.  Immunoreactivity in the contralateral hippocampus (right) was scarce. alv, 
alveus; or, stratum oriens; pyr, stratum pyramidale; rad, stratum radiatum; lm, stratum 
lacunosum moleculare; mol, molecular layer; hil, hilus; CA1, cornu ammonis 1; DG, 































expressed as a ratio of stain intensity of ipsilateral to contralateral DG stain.  In the 
case of mSuM microinjections, the relative DG stain was computed as a ratio of stain 
intensity of the left to the right DG.   
 
In experiments involving carbachol microinjection into the left lSuM, the total 
number of c-Fos positive neurons in the field CA1, 2 and 3 and the hilus of the 
ipsilateral hippocampus was significantly higher compared to the contralateral 
hippocampus (Fig 3.17, Table 4; P < 0.002, n = 10, two tail unpaired t-test).  In 
contrast, no difference was seen in c-Fos expression in the same regions with mSuM 
carbachol microinjection (Fig 3.17, Table 4; P > 0.1, n = 3, two tail unpaired t-test).  
lSuM carbachol microinjection also resulted in a more intense stain in the ipsilateral 
than the contralateral DG, while mSuM carbachol microinjection did not differentially 
activate the left or right DG (Fig 3.17, lSuM: 1.93 + 0.075, n = 11 vs mSuM: 0.96 + 
0.086, n = 3, P < 0.0003, two tail unpaired t-test).  Analysis of c-Fos expression in the 
hippocampus from experiments with lSuM carbachol microinjection showed a higher 
expression level in all layers (stratum oriens, pyramidale, radiatum and lacunosum 
moleculare) of the ipsilateral hippocampus in comparison to the contralateral 
hippocampus (Fig 3.18, Table 5; P < 0.03, n = 10, two tail unpaired t-test).    
 
3.5.3 Biochemical identification of c-Fos positive hippocampal non-pyramidal 
neurons 
 
Based on hippocampal c-Fos expression pattern, both pyramidal cells and 
interneurons are likely to be c-Fos positive.  To identify the biochemical nature of the 
labeled interneurons, a double immunofluoresence staining of selected hippocampal 
sections was carried out.  In this respect, neurons were labeled for c-Fos and  
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Fig 3.17  Microinjection of carbachol into the lSuM elicited a robust c-Fos expression 
in the ipsilateral but not the contralateral hippocampus fields CA1, CA2, CA3 and 
hilus (A).  In contrast, such lateralized c-Fos expression was not observed with mSuM 
carbachol microinjection (B).  In a similar fashion, following carbachol 
microinjection into the lSuM, the ipsilateral DG showed a more intense stain 
compared to the contralateral DG.  Conversely, mSuM carbachol microinjection did 
not evoked differential expression of c-Fos in the DG (C).  c-Fos positive neurons 
were quantified and averaged across six selected hippocampus sections in each 
animal.  The intensity of DG immunolabeling was computed as the ratio of stain 
intensity of ipsilateral to contralteral DG was obtained.  A ratio of 1 reflects a lack of 
diferential c-Fos expression between the left and right hippocampus.  See also Table 



























































































Table 4  Number of c-Fos positive neurons in CA1, CA2, CA3 and hilus of the ipsilateral and contralateral hippocampus following carbachol 
microinjection in the lateral or medial SuM.   
 
 
Microinjection site Section 
Number of c-Fos positive neurons in hippocampus regions 
CA1 CA2 CA3 Hilus 
Lateral SuM 
Ipsilateral 66.34 + 9.72 * 4.17 + 0.77 * 56.23 + 12.64 * 52.39 + 4.80 * 
Contralateral 17.68 + 3.49 0.74 + 0.27 6.79 + 1.28 4.19 + 2.38 
t-test statistic P < 0.0003 P < 0.0007 P < 0.002 P < 0.0001 
      
Medial SuM 
Left 22.11 + 0.71 2.15 + 0.50 16.88 + 3.28 8.63 + 2.85 
Right 14.52 + 3.78 2.25 + 0.88 11.16 + 3.03 15.56 + 7.54 
t-test statistic P > 0.1 P > 0.9 P > 0.2 P > 0.4 
 
 
The number of c-Fos positive neurons in each hippocampal subregion is the average value from 6 selected hippocampal sections – two sections each 
from the anterior (P2.30-2.80mm), middle (P3.14-3.80mm) and posterior (P4.80-5.30mm) hippocampus.  Ipsilateral and contralateral labels are with 






































Fig 3.18  Spatial analysis of c-Fos positive neurons in the ipsilateral and contralateral 
hippocampus field CA1 (A) and CA3 (B), following carbachol microinjection into the 
lSuM.  c-Fos expressing neurons in stratum oriens (Or), pyramidale (Pyr), radiatum 
(Rad) and lacunosum-moleculare (LM) were quantified.  In all layers, there was a 
robust expression of c-Fos protein in the ipsilateral hippocampus in comparison to the 
low c-Fos expression of the contralateral hippocampus.  The graph is built as in Fig 



















































































Number of c-Fos positive neurons in hippocampal layer 
Or Pyr Rad LM 
CA1 
Ipsilateral 44.72 + 4.79 * 68.49 + 8.54 * 44.85 + 9.63 * 16.94+ 4.37 * 
Contralateral 1.63 + 0.30 13.29 + 3.49 8.63 + 2.10 5.79 + 1.34 
t-test statistic P < 0.0001 P < 0.0001 P < 0.002 P < 0.003 
      
CA3 
Ipsilateral 17.10  + 3.27 * 54.82 + 9.01 * 44.16 + 6.30 * 4.82 + 2.06 * 
Contralateral 1.54 + 0.49 10.99 + 2.44 4.00 + 1.39 0.58 + 0.35 
t-test statistic P < 0.0002 P < 0.0002 P < 0.0001 P > 0.05 
 
Table is built as in Table 4.  The values are mean + S.E.M.  Or, stratum oriens; Pyr, stratum pyramidale; Rad, stratum radiatum; LM, stratum 




SOM, PV or nNOS, which are markers for hippocampal interneurons (Freund and 
Buzsaki, 1996).   
 
The pattern of c-Fos immunofluorescent label in hippocampus was similar to that 
described in previous section.  Within CA1, PV and nNOS expressing neurons were 
found in and around stratum pyramidale, some of which were also c-Fos positive.  
SOM expressing neurons were detected only in the stratum oriens (Fig 3.19F).  In 
contrast, PV and nNOS positive neurons in CA1 also colocalised c-Fos protein (Fig 
3.19I, arrows).   
 
Broadly, a similar pattern of colocalisation of c-Fos protein with other markers, 
especially PV and nNOS was observed in CA3.  Very few neurons were 
immunoreactive for SOM in field CA3 (Fig 3.20F).  However, colocalisation with c-
Fos protein was not distinctively observed (Fig 3.20I, arrows).   
 
The DG was observed as a dense band of c-Fos protein immunolabled structure with 
closely packed neuronal cell bodies (Fig 3.21).  In the DG, the cell bodies of PV 
expressing neurons were located within the granular layer of the DG and adjacent to 
the granular layer (Fig 3.21D).  PV positive neurons colocalised c-Fos protein were 
found adjacent to the granular layer but none of the PV positive neurons in the hilus 
were c-Fos positive.  Conversely, neurons expressing both nNOS and c-Fos proteins 
were found in the hilus (Fig 3.21H, arrows).  SOM expressing neurons were also 
distributed throughout the hilus region, some of which were c-Fos positive (Fig 















Fig 3.19  Confocal fluorescent images at 20X maginification showing the colocalisation of c-Fos protein and the interneuron markers 
parvalbumin (PV), neuronal nitric oxide synthase (nNOS) and somatostatin (SOM) in the field CA1 of the ipsilateral hippocampus following 
carbachol microinjection into the lateral supramammillary nucleus.  c-Fos protein expression is predominantly in the stratum pyramidale (pyr) 
although immunoreactivity is observed in stratum oriens (or) and radiatum (rad) of the hippocampus (A-C).  Some, but not all c-Fos positive 
































































































Fig 3.20  Confocal fluorescent images at 20X maginification showing the colocalisation of c-Fos protein and the interneuron markers 
parvalbumin (PV), neuronal nitric oxide synthase (nNOS) and somatostatin (SOM) in the field CA3 of the ipsilateral hippocampus following 
carbachol microinjection into the lateral supramammillary nucleus.  As in CA1, c-Fos protein expression is predominantly in the stratum 
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Fig 3.21  Confocal fluorescent images at 20X maginification showing the colocalisation of c-Fos protein and the interneuron markers 
parvalbumin (PV), neuronal nitric oxide synthase (nNOS) and somatostatin (SOM) in the dentate gyrus (DG) of the ipsilateral hippocampus 
following carbachol microinjection into the lateral supramammillary nucleus.  Intense c-Fos protein expression in the granular cells of the 
superior and inferior blades of the DG and the hilar region was observed (A-C).  Expression of PV, nNOS and SOM was predominantly localized 
in the hilar region (D-F) although in the case of PV, immunoreactive neurons were seen in the granular layer as well (D).  Scale bar represents 














































































4.1 Findings of the present study 
 
The present study tested the hypothesis that cholinergic mechanisms in the 
hypothalamic supramammillary nucleus (SuM) underpin, at least in part, the 
physiological modulation of the neural activity in the dorsal hippocampus field CA1 of 
the anaesthetized rat.  Indeed, in vivo electrophysiological investigation showed that 
microinjection of the cholinergic agonist, carbachol, into the SuM strongly reduced the 
amplitude of CA1 population spike (PS) and generated local hippocampal theta wave 
activity.  These effects of carbachol were antagonized by intra-SuM microinjection of 
the cholinergic-nicotinic receptor antagonist, mecamylamine, or the cholinergic-
muscarinic receptor antagonist, atropine.  Thus, pretreatment with mecamylamine or 
atropine reduced both the suppression of CA1 PS and the power of the theta wave 
activity evoked with microinjection of carbachol into SuM.  The effect of the two 
antagonists was selective such that they did not antagonize the comparable theta 
activation and PS suppression induced with SuM glutamate.  This selectiveness of 
effect is consistent with a receptor-mediated effect of the antagonists.  Consistent with 
this, both muscarinic and nicotinic receptors are localized in the SuM (Rotter et al., 
1979; Wada et al., 1989). 
 
Additionally, mecamylamine applied to the lateral SuM attenuated both the power of 
the theta wave activity and the PS suppression elicited by RPO stimulation or noxious 
sensory stimulation with hind paw injection of formalin.  Control microinjection of the 
vehicle into the lateral or the medial SuM did not influence the reticularly-elicited 
responses.  Similarly, microinjection of the muscarinic antagonist, atropine, into the 
lateral SuM did not influence the noxious stimulus-induced responses in CA1 even as 
the antagonist attenuated the intra-SuM carbachol-induced CA1 responses.  The 
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microinjection of atropine, therefore, acted as surrogate control for vehicle indicating 
that microinjection per se did not influence the responses in CA1 to peripheral noxious 
stimulation.  Interestingly, atropine in the lateral SuM antagonized only the generation 
of the theta power but not the suppression of the PS amplitude evoked on RPO 
stimulation.   
 
Immunocytochemical investigations showed that the cholinergic activation of SuM 
affected molecular plasticity in the hippocampus as well.  Thus, microinjection of 
carbachol into the lateral SuM evoked an increase in the number of c-Fos positive 
neurons in the ipsilateral hippocampal fields CA1, CA3, and the DG, c-Fos being a 
transcription protein that is expressed in neuron on synaptic excitation.  In contrast, 
little or no induction of c-Fos protein was observed with microinjection of the 
carbachol into the medial SuM.   
 
4.2 Cholinergic nicotinic receptor mechanisms in the SuM modulate 
hippocampal responses to physiological stimulation 
 
The foregoing data on the comparative effects of the two antagonists suggests that the 
nicotinic-receptor, rather than muscarinic-receptor mechanisms in the SuM, especially 
the lateral SuM region play a prominent role in the physiological regulation of 
hippocampal activity to reticular- and noxious-stimulation.  Indeed, a short latency 
antagonism was observed when mecamylamine was microinjected into lateral SuM; 
whereas little or no effect was observed with microinjection of the antagonist into the 
contiguous medial SuM.  On the other hand, atropine had a circumscribed effect, 
antagonizing only the RPO-elicited theta activity in CA1 when microinjected into the 
lateral SuM.  Microinjection of atropine into medial SuM had a much delayed effect 
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on reticularly-elicited theta power which is consistent with the spread of the drug, 
perhaps to lateral SuM, to exert an effect.  The lack of effect of lateral SuM atropine 
on suppression is also supported by the finding that the local administration of the 
antagonist did not influence the sub-maximal suppression seen with relatively low 
intensity RPO stimulation.  Moreover, the antagonists attenuated the robust PS 
suppression seen with intra-SuM carbachol suggesting that the lack of effect of 
atropine on physiologically-evoked PS suppression was not due to an inadequacy of 
the drug to antagonize cholinergic suppression per se.  The lateral SuM microinjection 
of the two antagonists per se did not influence basal PS and paired-pulse suppression 
during irregular EEG.  This strengthens the notion that the lateral SuM microinjection 
of the antagonists influenced CA1 pyramidal cells responses in an input specific 
fashion without affecting the basal properties of the CA1 pyramidal cells.   
 
Interestingly, the preferential localization of the effect of the antagonist to the lateral 
SuM region is consistent with the previous findings that this region is sensitive to the 
effect of the cholinergic agonist, carbachol, relative to the adjacent medial SuM, the 
dorsal region of the posterior hypothalamus, the lateral region of the medial forebrain 
bundle and the ventrally located mammillary bodies (Jiang and Khanna, 2006).  
Indeed and as previously shown, carbachol microinjection into the SuM in the present 
study evoked robust theta activation and suppression of CA1 pyramidal cell 
population spike at short latencies.  Whereas such microinjection in another 
contiguous area, namely the anterior VTA region, dorsal to the medial mammillary 
nucleus and medial to the substantia nigra, elicited hippocampal theta and the 
concurrent suppression of the CA1 PS at a much delayed latency.  Similarly, the effect 
of intra-VTA microinjection of the antagonists on carbachol-induced hippocampal 
activity was much delayed.  Collectively, the findings suggest that the drugs did not 
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act locally within VTA but rather diffused to other regions, perhaps the SuM, to exert 
an effect. 
 
Whether, the posterior VTA influences hippocampal activity remains unclear.  In this 
context, both the posterior VTA and the hippocampus have been linked to positive 
reinforcement (or reward) system.  For example, positive reinforcement behavior is 
observed with self administration of carbachol into the posterior, but not anterior VTA 
(Ikemoto and Wise, 2002).  Similarly, the hippocampus has been implicated in reward 
processing such that the entry of the animal into the cocaine-paired compartment in a 
conditioned place preference paradigm triggered theta selectively at entry, but not on 
entry into the compartment (Takano et al., 2010).  Furthermore, following receipt of a 
reward, the CA3 pyramidal cell activity is enhanced during sharp wave ripple activity, 
which is suggested to represent the recall of the preceding rewarded events (Singer and 
Frank, 2009).   
 
4.3 Diverse populations of neurons in the SuM modulate hippocampal 
responses to physiological stimulation 
 
The lack of complete cross-over in the effect of the atropine on reticularly- and 
formalin-induced CA1 responses indicates that the two stimuli evoke partly non-
overlapping activation of the lateral SuM.  A parsimonious scenario is that the 
reticularly-elicited CA1 theta power, but not PS suppression, is modulated in part by 
muscarinic-cholinoceptive neurons in the lateral SuM since only CA1 theta power is 
attenuated by the antagonist.  On the other hand, separate populations of neurons that 
are sensitive to mecamylamine, and constituting the nicotinic-cholinoceptive neuronal 
population, also modulate reticularly- and formalin-elicited CA1 PS suppression and 
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theta activation.  Interestingly, in a previous study microinjection of the inhibitory 
ligand, GABA, into the lateral SuM antagonized the reticularly-elicited theta power 
but not CA1 PS suppression (Jiang and Khanna, 2004).  This raises the possibility that 
within the population of nicotinic-cholinoceptive neurons in lateral SuM there are 
those that are relatively GABA insensitive and mediate CA1 PS suppression elicited 
by both the physiological stimuli, whereas others which, together with the muscarinic-
cholinoceptive neurons, are GABA sensitive and mediate theta activation to the two 
stimuli.   
 
The SuM has been shown to facilitate frequency transduction of hippocampal theta 
elicited by reticular stimulation (Kirk and McNaughton, 1993; Kirk, 1998).  However, 
the present evidence does not support a direct role for cholinergic synaptic 
transmission in the lateral SuM in generation of the phasic rhythm (or oscillations) that 
underpins theta rhythmicity in CA1.  Thus, neither atropine, nor mecamylamine 
microinjected into lateral SuM attenuated theta generation per se, given that the theta 
peak frequency in CA1 was not influenced by the two antagonists; whereas, intra-SuM 
microinjection of benzodiazepines that act as the positive allosteric modulators of 
GABA receptor function decreased the frequency of reticularly elicited CA1 theta 
(McNaughton et al., 1995).  Indeed, SuM neurons discharge in theta rhythmic fashion 
(Kirk and McNaughton, 1991; Bland et al., 1995; Kocis and Vertes, 1997) and such 
neuronal activity is suggested to underpin, at least in part, the generation of the theta 
rhythm in hippocampus (Pan and McNaughton, 2004).  The interplay of synaptic 
transmission, including cholinergic and GABAergic, in the generation of theta 
rhythmic neuronal activity in SuM remains to be elucidated.  There is a precedent in 
the hippocampus where the septohippocampal cholinergic input is suggested to evoke 
tonic excitation of the CA1 GABAergic interneurons whose activity is sculpted into 
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theta rhythm by rhythmic inhibition from septohippocampal GABAergic neurons 
(Buzsaki, 2002).  In turn, the CA1 interneurons rhythmically modulate the activity of 
CA1 principal neurons.   
 
4.4 Nociceptive processing in the supramammillary nucleus is lateralized 
 
Mecamylamine, microinjected into lateral SuM, antagonized the effect of formalin 
injection on CA1 neural activities in a lateralized fashion.  Thus, the drug attenuated 
both theta activation and PS suppression induced by injection of formalin into the 
contralateral, but not ipsilateral hind paw.  This selectivity strengthens the notion that 
the effect of mecamylamine was input selective and not due to a generalized inhibition 
of theta activation and PS suppression or due to a generalized attenuation of 
nociceptive processing.  Here it is notable that: (a) the lateral SuM and the medial 
septum are connected by reciprocal connections that are predominantly ipsilateral 
(Vertes, 1988; 1992; Borhegyi et al., 1998; Leranth et al., 1999); (b) the 
supramammillary-septal afferents innervate both the cholinergic and parvalbumin 
positive GABAergic septohippocampal afferents (Leranth and Kiss, 1996; Borhegyi et 
al., 1998); (c) acetyl cholinesterase-positive, putative cholinoceptive neurons are 
observed in the lateral SuM region (Parent and Butcher, 1976); (d) cholinergic 
activation of lateral SuM suppresses CA1 PS and evokes theta activation via the MS-
VLDBB (Jiang and Khanna, 2006); and (e) the formalin-induced PS suppression and 
theta activation are attenuated by destruction of MS-VLDBB cholinergic neurons 
(Zheng and Khanna, 2001).  The present study extends the findings by suggesting the 
relay of nociceptive relay from SuM to MS-VLDBB that is modulated by cholinergic 




The cholinergic neurons that might be recruited upon RPO- and noxious-stimulation to 
modulate SuM remain uncertain.  One possibility is that non-cholinergic, perhaps 
aspartate/glutamatergic (Kiss et al., 2002) afferents activated on reticular- and 
noxious-stimulation excited choline acetyltransferase positive (Tago et al., 1987), 
putative cholinergic neurons within the lateral SuM.  In turn, these cholinergic neurons 
modulated SuM neural activity via release of acetylcholine.  However, the theta 
activation and PS suppression elicited by lateral SuM microinjection of the glutamate 
were not antagonized by either of the two cholinergic antagonists.  This, however, 
does not exclude the idea that glutamatergic afferents separately affect SuM during 
RPO- and/or noxious stimulation, especially since we have not explored the effects of 
intra-SuM microinjection of glutamate receptor antagonists on hippocampal responses 
evoked by the two stimuli. 
 
Another option is that the RPO electrical stimulation and the peripheral noxious 
stimulus excite cholinergic afferents to lateral SuM.  In this context, the RPO region 
interacts with the LDTg that projects to SuM via cholinergic afferents (Vertes and 
Martin, 1988; Semba and Fibiger, 1992; Gonzalo-Ruiz et al., 1999; Sukhotinsky et al., 
2007).  Indeed, neurons in the RPO region and the LDTg respond to peripheral 
noxious stimulation (Hanada et al., 1999; Carlson et al., 2005).  Further, anatomical 
and electrophysiological studies indicate that the RPO and the LDTg receive spinal 
inputs, including nociceptive inputs from the contralateral spinal cord (Menetrey et al., 
1980; Shammah-Lagnado et al., 1987; Semba and Fibiger, 1992).  Thus, 
cholinoceptive neurons in the lateral SuM region (Parent and Butcher, 1976) may be 
recruited by ascending cholinergic inputs activated by the two physiological stimuli 




4.5 Cholinergic activation of supramammillary nucleus induces c-Fos protein 
 
Following carbachol microinjection into the lateral SuM, c-Fos protein was 
immunohistochemically detected in all layers of the ipsilateral hippocampus, 
especially the dentate gyrus granule cell layer where the labeling of the tightly packed 
granule cells was observed as a dark band.  The expression was observed throughout 
the medial-lateral extent and along the length of the dentate gyrus.  Since c-Fos is 
expressed in neurons on synaptic excitation, the finding suggests robust excitation of 
DG granule cells with intra-SuM carbachol.  Indeed, electrical or chemical stimulation 
of the lateral SuM enhances granule cell excitability, in part via disinhibition 
(Mizumori et al., 1989; Carre and Harley, 1991; Nakanishi et al., 2001; see section 
1.3.2).  Nonetheless, the relative robust excitation of DG by carbachol microinjection 
into the SuM did not evoke a commensurate excitation of other principal neurons 
along the trisynaptic pathway given that only few neurons in the pyramidal cell layers 
of field CA3 and CA1 were labeled with c-Fos.   
 
It is interesting to note that SuM is also linked to excitation of the septohippocampal 
network during epilepsy.  Thus, microinjection of the glutamate receptor agonist, 
kainic acid, into the basal-lateral region of the amygdala evoked epileptic behavior, 
hippocampal epileptic discharges and a sequential induction of c-Fos that appeared 
first in the entorhinal cortex followed by DG and lastly within the fields CA1, CA3 
and the septum (Saji et al., 2000).  The induction of c-Fos in fields CA1 and CA3 was 
robust unlike that seen presently.  Importantly, inactivation of the SuM with 
microinjection of the GABA mimetic, muscimol attenuated the induction of c-Fos in 
DG and fields CA1 and CA3 together with inhibition of behavioral and hippocampal 
neural indices of epilepsy.  On one hand, this corroborates our findings that excitation 
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of SuM triggers c-Fos molecular plasticity in DG.  But, on the other hand, also 
suggests that the SuM-mediated activation of hippocampal principal neurons outside 
of the DG occurs potently under exceptional circumstances, such as seen during 
epileptic spiking, which is not seen with the cholinergic activation of SuM in our 
study.   
 
Indeed, the pattern of activation of DG granule cells upon SuM stimulation may 
influence the relative strength of excitation of CA3 pyramidal cells and presumably, 
therefore, the induction of c-Fos in the region.  For example, in vivo and in vitro data 
suggests that the probability of CA3 pyramidal cells discharge is quite low at firing 
rate of < 10Hz for granule cells which is consistent with the high failure rate of 
excitatory synaptic transmission at mossy fibre-CA3 pyramidal cells synapse at such 
low firing rates of the granule cells (Henze et al., 2002; Mori et al., 2004).  On the 
other hand, at higher firing rates (especially burst discharge) of the granule cells, the 
EPSP at mossy fibre-CA3 pyramidal cell is facilitated whereas the underlying IPSP 
that modulates excitation is suppressed (Mori et al., 2004).  
 
Further, data from the present and previous studies from the laboratory have 
consistently indicated that activation of the SuM inhibits the excitatory transmission 
along the trisynaptic pathway, especially the Schaffer collaterals input to pyramidal 
neurons in field CA1 (Jiang and Khanna, 2004, 2006; Ariffin et al., 2010).  Indeed, the 
SuM mediated inhibition is marked by decrease in the slope of the field excitatory 
postsynaptic potentials recorded from the soma or the dendrites of the CA1 pyramidal 
cells (Jiang and Khanna, 2004, 2006).  Moreover, the double label 
immunofluorescence in the present study also revealed that activation of the SuM 
excited hippocampal inhibitory interneurons which may reinforce the inhibition of 
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principal neurons in the field CA1 and CA3 and weigh against the induction of c-Fos.  
Thus, PV, nNos and SOM positive neurons are all GABAergic inhibitory interneurons 
whose axons terminates on pyramidal cells or dendrites of the hippocampus fields 
CA1 and CA3 and granule cells in DG (Köhler and Chan-Palay, 1982; Kosaka et al., 
1987; Nitsch et al., 1990; Ribak et al., 1990; Valtschanoff et al., 1993; Sik et al., 1995; 
Freund and Buzsaki, 1996; Katona et al, 1999).   
 
However, the effect of inhibition of dentate granule cells by interneurons may be 
offset, at least partly, by the dense, presumably glutamatergic excitatory input to the 
region from the SuM, especially the lateral SuM, whereas the projection from SuM to 
hippocampus is less pronounced and mostly to CA3 and CA2 (Haglund et al., 1984; 
Vertes, 1992; Magloczky et al., 1994; Kiss et al., 2000).  Interestingly, while the SuM 
axons form a dense network around proximal dendrites and soma of the principal cells, 
synapse on local interneurons is not observed (Magloczky et al., 1995).  Conversely, 
we have provided evidence that SuM stimulation suppressed CA1 synaptic excitability 
via activation of the medial septum (Jiang and Khanna, 2006).  In this context, 
procaine mediated inactivation of the medial septum attenuated suppression of CA1 
population spike amplitude following intra-SuM carbachol microinjection.  This 
suggests that the inhibitory modulation of hippocampal excitability by the SuM is 









4.6 Functional significance of results 
 
Based on the present and previous findings from the laboratory, we suggest that the 
cholinergic mechanisms in the lateral SuM, and the septohippocampal cholinergic 
neurons, comprise part of an ascending system of cholinergic and cholinoceptive 
neurons that facilitate ‘signal-to-noise’ processing in the hippocampal field CA1 (see 
Fig. 4.1).  As part of that function, the ascending system from the SuM inhibits 
excitation of CA1 pyramidal cells, especially to intrinsic excitatory input from 
components of the trisynaptic pathway.  At the same, the network of cholinergic and 
cholinoceptive neurons of the ascending relay facilitates the generation of 
hippocampal theta which is implicated in temporal encoding of information whereby 
select population of CA1 pyramidal cells discharge rhythmically to external inputs 
(i.e. ‘signal’) such as during exploration and upon peripheral application of noxious 
stimulus (see section 1.2.3 in ‘Introduction’).   
 
Such ‘signal-to-noise’ modulation of hippocampal field CA1 neural activity might be 
a neural basis of behavioral arousal/attention, at least in part.  Indeed, an increase in 
release of hippocampal acetylcholine and activation of SuM neurons is observed when 
an animal is placed in a novel environment (Emmert and Herman, 1999; Giovanini et 
al., 2001; Ito et al., 2009).  And the novelty induced hippocampal c-Fos is sensitive to 
antagonism by cholinergic receptor antagonist, atropine (Wirtshafter, 2005).  
Conversely, lesion of septohippocampal cholinergic neurons, which attenuates ‘signal-
to-noise’ processing (see Fig. 4.1), affects attention in behaving animals (Baxter et al., 
1997).  Furthermore, such signal to noise processing has been implied in the 




Seen in the context of the foregoing the current findings point to the possibility that 
the SuM nicotinic neurons are part of cholinergic SuM-septohippocampal network 
involved in the modulation of behavioral arousal to persistent nociception.  More 
broadly, this system may subserve similar role, at least partly, in behaviors where SuM 
is involved including positive reinforcement associated with nicotine microinjection 
into the SuM (Ikemoto et al., 2006).  And, indeed, activation of mecamylamine 
sensitive nicotinic mechanisms in the posterior hypothalamus evoked increased 
locomotion (Buccafusco and Brezenoff, 1980).  Conceivably, therefore, the SuM 
nicotinic mechanism is triggered as part of intra- and extra-SuM consortium of neural 
substrates that are recruited during behavioral activation and influence neural 
network(s) in the hippocampal formation (Thinschmidt et al., 1995; Bland and Oddie, 












Fig 4.1  Schematic diagram summarizing the findings of the current study.  Cholinergic nicotinic 
(nAChR) and/or muscarinic (mAChR) receptor mechanisms in the lateral supramammillary region 
(SuM) affect hippocampal neural activity to the stimuli shown on the figure.  The neural changes 
observed include the carbachol-induced expression of c-Fos (+), a marker of synaptic neuronal 
excitation, in the granule cell layer of the dentate gyrus (DG) of the hippocampal formation.  This is 
consistent with earlier findings that SuM facilitates the synaptic excitability of DG granule cells 
(Carre and Harley, 1991).  Conversely, the disproportionately low induction of c-Fos in the 
pyramidal cell layer of hippocampus, especially in field CA1, on cholinergic activation of SuM 
parallels the suppression of CA1 synaptic excitability to CA3 stimulation (-).  Notably, the CA3 is 
the conduit for the relay of excitation from DG to CA1.  The parallel between the 
immunhistochemical and electrophysiological findings strengthen the notion that activation of the 
SuM suppresses the excitation of CA1 pyramidal cells to intrinsic excitatory input from the CA3 
and the DG, both of which are the components of the trisynaptic excitatory pathway to CA1.  
Interestingly, the weight of evidence suggests that the septohippocampal cholinergic neurons 
mediate, at least partly, the SuM mediated suppression of CA1 synaptic excitability (Zheng and 
Khanna, 1999; Jiang and Khanna, 2004, 2006).  Indeed, intrahippocampal cholinergic mechanisms 
inhibit field CA1 pyramidal cell excitability, both by presynaptic inhibition and by excitation of 
local interneurons (Chapman and Lacaille, 1999; Reich et al., 2005).  Similarly, 
immunohistochemical evidence from the present study suggests that intra-SuM cholinergic 
activation recruits a network of interneurons in the hippocampus which could directly inhibit 
activation of CA1 pyramidal cells.   
 
Moreover, the lateral SuM cholinergic mechanisms generate medial septum mediated hippocampal 
theta activation, specifically affecting the amplitude of theta wave activity.  Theta wave activity is a 
3-12 Hz sinusoidal rhythmic extracellular waveform reflecting intracellular membrane potential 
oscillations and is implicated in temporal-encoding of information in the region (Bland, 1986; 
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